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Abstract 
Mycobacterium tuberculosis, the causative agent of the infectious disease 
tuberculosis, has a distinct lipid-rich cell wall which not only provides physical 
protection to the bacilli, but also plays an important role in virulence. Several 
currently used anti-TB drugs target cell wall biosynthetic pathways. Therefore, a good 
understanding of the structure and biosynthesis of the cell wall will provide helpful 
clues for the development of novel anti-Mycobacterium drug targets, as well as a 
better understanding of Mycobacterium-host cell interactions. 
To study cell wall biosynthesis in mycobacteria, a strategy based on random 
transposon (Tn) mutagenesis with two different screening criteria, altered colony 
morphology and mycobacteriophage resistance, was developed. Two model systems, 
non-pathogenic Mycobacterium smegmatis and the fish pathogen Mycobacterium 
marinum were used for generating Tn-mutant libraries. From the colony morphology 
screen, two out of eight genes identified from M. smegmatis Tn-mutants and eleven 
out of twenty from M. marinum Tn-mutants with altered colony morphology were 
directly involved in cell wall synthesis. Genes with an indirect impact on colony 
morphology were also identified. One mutant from each species was chosen for 
further study. First was the M. smegmatis 3D9 Tn-mutant with the only isocitrate 
dehydrogenase (icd) gene disrupted. Although there were no differences in lipid 
profiles, fatty acids and mycolic acids, it was an ideal surrogate to study different 
orthologues of M. tuberculosis icds. The second mutant described in these studies was 
the M. marinum 8G10 mutant with a Tn inserted into the promoter region of 
MMAR0978 with a deficiency in methoxymycolates production. The virulence of the 
8G10 mutant was tested using murine bone marrow derived macrophages and the 
zebrafish infection model, with the mutant found to be attenuated in the latter. 
The generalised transducing phage I3 was chosen for isolating 
mycobacteriophage resistant M. smegmatis Tn-mutants. Four I3-resistant mutants 
 II
were identified with a Tn insertion in a gene cluster involved in the biosynthesis of the 
cell wall associated glycopeptidolipids (GPLs) and loss of GPLs in the mutants was 
confirmed, demonstrating the potential of using phage-resistant mutants for 
identifying cell wall biosynthetic genes. The minimal phage I3 receptor in M. 
smegmatis was further identified by using a set of previously described M. smegmatis 
mutants that produced truncated GPL intermediates. 
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 2
1.1 History 
Tuberculosis (TB) is an infectious disease caused by the bacterium 
Mycobacterium tuberculosis that primarily affects the lungs, but may also spread to 
other parts of the body. It is an ancient disease that has plagued mankind for 
thousands of years. The oldest case of human TB, from Atlit-Yam in the Eastern 
Mediterranean (9250-8160 years old), was confirmed by PCR analysis for M. 
tuberculosis genetic loci and high performance liquid chromatography for M. 
tuberculosis specific mycolic acid lipid biomarkers (Hershkovitz et al., 2008). 
Through history, TB has been referred to by different names. Phthisis was used in 
Greek literature around 460 BC for its characteristics of fever, cough and loss of 
appetite. It was also referred to as the white plague in Europe for its association with 
anaemia and high mortality in the 17th century epidemic which lasted for about 200 
years and caused more than 1 billion deaths (Dormandy, 1999).  
Records of theories for the cause of TB can be also found throughout history. 
While ancient Greeks believed that TB was hereditary, Aristotle suggested that it was 
contagious (Madkour, 2004). Girolamo Fracastoro, a Venetian physician in the 16th 
century, first proposed that it was caused by transferable tiny particles via direct or 
indirect contact (Brock, 1998). In 1819, the French physician Rene Laennec published 
his book explaining the pathogenesis of TB, the correspondence between pulmonary 
lesions and respiratory symptoms in TB patients (Daniel, 2000). In 1869, Jean 
Antoine Villemin proved that TB was contagious using animal experimental models 
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(Barnes, 1995). However, the defining moment in the history of the disease came in 
1882, when Robert Koch presented his discovery that the bacterium, M. tuberculosis, 
was the causative agent of TB at the Physiological Society of Berlin (Koch, 1982). 
Later in 1890, he also developed tuberculin, a protein preparation from M. 
tuberculosis, which was ineffective for immunisation, but was subsequently found 
useful in the diagnosis of TB by Charles Mantoux in 1908. The Mantoux Test, as it is 
called now, is still wildly used as a TB diagnostic method (Madkour, 2004).  
1.2 TB chemotherapy and vaccination 
TB is treated with a combination of drugs because of the high risk of developing 
drug resistance when using single drugs (Wang et al., 2006). A standard treatment for 
TB includes: 2 months of isoniazid (INH), rifampicin (RMP), pyrazinamide (PZA) 
and ethambutol (EMB), which is then followed by 4 months of INH and RMP. As for 
latent TB, 6-9 months treatment of INH and RMP after 2-month standard treatment is 
recommended by WHO (World Health Organization). Because of the long course of 
therapy, patients show poor adherence/compliance which is also one of the causes of 
the appearance of drug resistance. WHO launched DOTs (directly observed therapy, 
short-course) to help ensure patient’s compliance, as a part of a global TB eradication 
program, which includes government commitment to control TB, diagnosis based on 
sputum-smear microscopy tests done on patients who actively report TB symptoms, a 
supply of drugs and standardised reporting and recording of cases and treatment 
outcomes (Elzinga et al., 2004). Statistical studies revealed that DOTs can 
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successfully prevent the emergence of multi-drug resistance (MDR-TB) strains and 
their recurrence.  
Anti-TB drugs belong to three categories according to WHO guidelines (WHO, 
2003) based on their mode of action and side-effects. The first-line (essential) drugs 
include INH, RMP, PZA, EMB and streptomycin (STM). The second-line (reserved) 
drugs, which are less effective or with more side-effects compared to first-line drugs, 
include six classes: aminoglycosides (e.g. kanamycin), polypeptides (e.g. 
capreomycin), fluoroquinolones (e.g. ciprofloxacin), thioamides (e.g. ethionamide), 
cycloserine, p-aminosalicylic acid. Third-line drugs which are less effective (or the 
efficacy has not been proven yet) include rifabutin and macrolides. Structures of some 
of the anti-TB drugs in use are shown in Fig. 1.1.  
Fig. 1.1 Structures of some commonly used TB drugs.  
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A majority of them target mycobacterial cell wall biosynthetic pathways as shown in 
Table 1.1 (Zhang, 2005).  
Table 1.1 Commonly used TB drugs and their mechanisms (Zhang, 2005) 
Drug Mechanisms of Action 
Isoniazid Inhibition of cell wall mycolic acid synthesis; effects on DNA, lipids, carbohydrates 
and NAD metabolism 
Rifampin Inhibition of RNA synthesis 
Pyrazinamide Disruption of membrane transport and energy depletion 
Ethambutol Inhibition of cell wall arabinogalactan synthesis 
Streptomycin Inhibition of protein synthesis 
Kanamycin Inhibition of protein synthesis 
Quinolones Inhibition of DNA synthesis 
Ethionamide Inhibition of mycolic acid synthesis 
PAS Inhibition of folic acid and iron metabolism 
Cycloserine Inhibition of peptidoglycan synthesis 
While the first anti-TB drug streptomycin was discovered in 1944, and it was 
followed with a golden era in the 1950s and 1960s of antibiotic discovery, no more 
new anti-TB drugs have been launched during the last 50 years. Utilising genomic 
information, several potential new drug targets have been identified and have been 
used for lead compound screening. For example, R207910, a diarylquinoline, is an 
inhibitor of the membrane bound ATP synthase and shows activity against both 
drug-sensitive and MDR- M. tuberculosis (Andries et al., 2005; Koul et al., 2007); 
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inhibitors of the two component system DosR/S, which is responsible for the response 
to the host immune defence mechanisms may have an effect against W-Beijing 
hypervirulent strains of M. tuberculosis (Reed et al., 2007). Furthermore, several new 
drug candidates are currently in clinical trials (Barkan et al., 2009; Guy & 
Mallampalli, 2008), such as TMC-207 (former R207910); nitroimidazopyran PA-824 
which blocks cell wall protein and lipid synthesis and is active against both 
replicating and non-replicating M. tuberculosis (Tyagi et al., 2005); SQ 109, a 
derivative of ethambutol, with potent activity against drug-sensitive and MDR- M. 
tuberculosis (Chen et al., 2006). 
To fight against infectious disease, apart from medication after its establishment, 
vaccination is another important method to protect humans from being infected. 
Facing human immunodeficiency virus (HIV) co-infection and the emergency of 
untreatable MDR and extensively drug resistant (XDR) - M. tuberculosis, an effective 
TB vaccine is essential. BCG, an attenuated live vaccine, is currently the only 
available vaccine against TB. In the early 1900s, Albert Calmette and Camille Guerin 
noticed the reduction of virulence of M. bovis, a strain that caused bovine TB, during 
passage under laboratory conditions. After a 13-year continual in vitro passaging of 
this strain and trials on different animal models, they did the first human trial in 1921, 
which showed protection against TB (Behr, 2002; Oettinger et al., 1999). Later this 
BCG strain was distributed to laboratories around the world. A subsequent sub-culture 
across the globe resulted in a continued evolution of BCG, and worldwide, BCG now 
represents not a single strain but a group of sub-strains with varying degrees of 
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deletion (Behr & Small, 1999; Behr et al., 1999). 
Despite that, BCG has already been used worldwide for decades; its protective 
efficacy remains contentious, especially in adults. BCG can provide more than 80% 
protection against severe forms of TB, like miliary TB in children (Trunz et al., 2006), 
but its protection against pulmonary TB in adults ranges from 0-80% (Brewer, 2000).  
A better understanding of the mechanism in BCG attenuation can be helpful to 
address its variation in protective efficacy. With the advance of genomic techniques 
and knowledge of pathogenicity of M. tuberculosis, the mechanisms underlying BCG 
attenuation begin to be unveiled. Compared with M. tuberculosis and M. bovis 
virulent strains, BCG contains a deletion, termed Region of Defference-1 (RD1). 
Results based on studies in M. tuberculosis show that RD-1 includes genes encoding 
proteins essential for growth in macrophages or important for virulence (Guinn et al., 
2004; Stanley et al., 2003). In addition to the loss of RD-1, further studies have shown 
that other changes are also involved, for instance the loss of specific cell-wall lipids 
(PDIM, phthiocerol dimycocerosate and PGL, phenolic glycolipid) (Rao et al., 2006) 
and mutations in virulence related two-component systems, phoP-phoR (Leung et al., 
2008).  
In addition to the numerous genome differences between BCG and M. 
tuberculosis revealed by comparative genomic analysis, studies have also provided 
evidence which shows differences in the immune response between BCG vaccination 
and M. tuberculosis infection, especially M. tuberculosis induced CD8+ T cell 
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responses, which has been considered as a major contribution against the disease 
(Caccamo et al., 2009; Woodworth & Behar, 2006). Therefore, there are two main 
strategies used for developing new vaccines based on our current understanding of M. 
tuberculosis infection, and the use of specific genetic tools. One approach is to 
improve the efficacy of BCG by expressing recombinant M. tuberculosis antigenic 
proteins (known as recombinant BCG, rBCG) (Bastos et al., 2009; Grode et al., 2005; 
Horwitz, 2005) or boosting BCG vaccination using M. tuberculosis antigen 
protein/protein units or antigen encoding viral vectors (Reed et al., 2009; Tchilian et 
al., 2009). The second strategy is to generate M. tuberculosis attenuated strains by 
knocking out genes involved in replication or virulence (Aguilar et al., 2007; Waters 
et al., 2007). Two rBCG candidates are in phase 1 clinical trials (Walker et al., 2010), 
whilst another rBCG expressing M. tuberculosis Antigen 85B has entered phase I 
clinical trials in 2004 (Horwitz, 2005). 
1.3 Resurgence of TB 
After improvement in public health and sanitation, and introduction of the BCG 
vaccine and antibiotics in clinical treatment, the incidence and mortality of TB 
steadily declined in developed countries until the 1980s. However, in the mid-1980s, 
the incidence of TB increased in North America and Western Europe (Raviglione et 
al., 1993; Rieder et al., 1989), as well as in developing areas, such as Africa and 
Southern Asia (Corbett et al., 2003; Raviglione et al., 1995).  
The WHO announced TB as a global epidemic in 1993 and estimated that more 
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than 2 billion people, approximately a third of the global population, were infected 
with the TB bacillus. In 2008, there were about 9.4 million new cases of TB, of which 
55% occurred in Asia and 30% in Africa (Fig. 1.2). India, China and South Africa 
ranked among the top three countries for incidence of TB. Of the new cases, 13-16% 
were HIV-positive. Meanwhile, there were 11.1 million cases worldwide in 2008, a 
decrease from 13.7 million in 2007 and 13.9 million in 2006. In 2008, about 1.8 
million people died of TB, of which 0.5 million were HIV-positive (WHO, 2009a; 
WHO, 2009b). 
 
 
 
 
Fig. 1.2 Estimated TB incidence rates, 2008 (WHO, 2009a). 
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A major factor, for the resurgence of TB, is the spread of HIV. HIV co-infection 
raised the risk of developing active TB in a population with latent TB, from 5-10% 
during their lifetime, to the same risk in one year (CDC, 1998; Cole et al., 1998; 
Corbett et al., 2003). 
An additional factor is the emergence of MDR - M. tuberculosis strains in the 
past several decades. Incomplete/inadequate treatment and poor 
adherence/compliance to therapy are two main reasons for the appearance of MDR - 
M. tuberculosis strains. In WHO 2008 report, it was estimated that about 490,000 
cases of MDR-TB emerged every year and caused more than 110,000 deaths; nearly 
half of the burden occurred in China and India (WHO, 2008). Amongst new TB cases, 
2.9% were MDR-TB, compared with 15.3% amongst previous treated cases (WHO, 
2008) (Fig. 1.3).  
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Furthermore, this problem has been compounded by the recent emergence of 
XDR-TB, which are resistant to RIF, INH, fluoroquinolones and at least one of the 
three injectable second-line drugs (capreomycin, kanamycin, and amikacin). This 
form of TB, which is almost incurable, was first reported in 2005, when 52 out of 53 
Fig. 1.3 Global incidence of MDR-TB. A. MDR-TB among new cases 1994-2007; B. 
MDR-TB among previously treated cases 1994-2007 (WHO, 2008) 
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patients died within a median period of 16 days (from TB test to death) (Gandhi et al., 
2006). Now, 58 countries have at least one XDR-TB case confirmed (Fig. 1.4) (WHO, 
2010).  
 
1.4 The biology of pulmonary M tuberculosis infection 
TB is an airborne disease and thus the primary site of TB infection is the lung 
(pulmonary TB). Symptoms of pulmonary TB are chest pain, prolonged cough, fever, 
and appetite and weight loss. Extrapulmonary TB can occur in the central nervous 
system, lymphatic system, bones and joints (Be et al., 2009; Kaufmann, 2001). An 
extreme form of extrapulmonary TB with a close to 100% mortality rate is 
disseminated TB, also known as miliary TB, in which the bacteria enter the blood 
stream and seed infection in several organs via the circulatory system (Bolognia et al., 
Fig. 1.4 Distribution of countries and territories (in red) reporting at least one case of 
XDR-TB as of January 2010 (WHO, 2010). 
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2008; Lessnau & Luise, 2009).  
Not all M. tuberculosis infections can lead to active TB. Following inhalation, a 
number of fates are possible for the inhaled bacteria. In most cases, the host immune 
response is strong enough to ‘clean’ the bacilli, resulting in no infection. The bacteria 
could also proceed to the alveoli where they are engulfed by macrophages, which 
triggers the innate immune response followed by an adaptive immune response. Then 
activation of the host immune system initiates the development of a granuloma. A 
granuloma represents a dynamic interaction between different immune cells, such as 
T cells, macrophages and dendritic cells (DCs). If the host is weak, the bacilli can not 
be eliminated or restrained, leading to active TB. If the host immune system is 
competent, the bacteria can be withheld in granulomas, causing latent infection with 
no symptoms. Once the host immune condition changes that breaks the balance in the 
granuloma, thus the alive bacteria will be released and cause TB reactivation. 
In TB infection, after the entry into the lung by airborne transmission of tiny 
droplets produced by an active TB patient (Cole, 2005; Zahrt, 2003), M. tuberculosis 
is engulfed by alveolar macrophages from the innate immune response using mannose 
receptors (MR) and Toll-like receptors (TLR) that are considered as the first line of 
defence against infection. To survive and replicate in macrophages, M. tuberculosis 
adopts several strategies to escape the antimicrobial defence mechanisms of 
macrophages. First, it can arrest phagosome maturation (Fratti et al., 2003; Vergne et 
al., 2003; Vergne et al., 2005) and block phagosome-lysosome fusion (Walburger et 
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al., 2004) to avoid being degraded. Second, genes in the bacilli, such as katG and 
sodC, as well as cell wall components, such as lipoarabinomannan (LAM), can help 
M. tuberculosis resist intracellular oxidative stress (Chan et al., 1991; Piddington et 
al., 2001; Stover et al., 1991; Wu et al., 1998). Also, M. tuberculosis can maintain 
access to essential nutrients for intracellular replication by intercepting with the 
endocytic system (Sturgill-Koszycki et al., 1996).  
Besides the innate immune response, the adaptive immune response is also 
important. M. tuberculosis is also exposed to dendritic cells (DCs), antigen presenting 
cells which are important for activating T cell-related adaptive immune responses at 
the site of infection. Although, DCs can not eliminate engulfed M. tuberculosis, 
unlike macrophages, DCs do not allow it to grow intracellularly (Tailleux et al., 2003). 
To activate naïve T cells, DCs have to migrate to drainage lymph nodes which help to 
further disseminate the bacilli (Banchereau et al., 2000; Meya & McAdam, 2007; 
Wolf et al., 2008). During TB infection, CD1b molecules responsible for presenting 
lipid antigens play an important role. Virulence related cell wall components, such as 
LAM and phosphatidylinositol mannosides (PIMs), have been reported to be 
presented by CD1 (Sieling et al., 1995). However, the exact function of 
CD1b-restricted T cells in anti-TB immune response is not clear yet. As for B cell 
induced humoral response, there is still no consistent results for its contribution 
against TB, although it has been demonstrated that B cells can contribute to the fight 
against some intracellular bacteria and parasites (Maglione & Chan, 2009) and 
modulate T cell responses via antigen-presenting, priming memory T cells and 
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cytokines (Andersen et al., 2007; Harris et al., 2000; Igietseme et al., 2004; Lund et 
al., 2006). Data from human and animal models suggests that anti-TB immunity is 
based mainly on CD4+ Th1-mediated activation of phagocytes to destroy intracellular 
bacilli through the IFN-γ and IL-12 pathways (Boom, 1996; Cooper et al., 1993; 
Cooper et al., 1997; Flynn et al., 1993; Flynn & Chan, 2001). However, the Th1 
immune response is important as it stops the expansion of infection by taking part in 
the formation of granulomas (Russell, 2007), although it is not enough for eliminating 
the infection. In contrast to the CD4+ T cell response, the CD8+-mediated cytotoxic 
response to TB is still not fully understood.  
Granuloma formation represents a critical manifestation in TB infection not only 
as a pathological symptom but as determination of disease progression. It starts when 
the bacteria are phagocytosed by alveoli macrophages. At this early stage, the bacilli 
replicate at a rapid rate within macrophages to trigger a cellular immune response, 
while the infected macrophages initiate a proinflammatory response at the site of 
infection and start to differentiate into different types, such as giant cells and foamy 
macrophages. Tubercules are formed, composed of infected macrophages surrounded 
by foamy macrophages and other phagocytes in the middle and further surrounded by 
lymphocytes. Then, the bacilli stop the rapid replication followed by the development 
of fibrous capsule to separate the tubercule and lymphocytes which represents the 
maturation of granulomas (Fig. 1.5) (Russell, 2007; Russell et al., 2009). Up till this 
stage, the granuloma functions as a container of the bacteria and prevents its 
dissemination which leads to latent infection. When the immune status of the host 
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changes, for instance old age or poor immunity, such as HIV infection, the granuloma 
breaks down and the live bacilli are released into the airway and transmitted, as is 
termed ‘reactivation of TB’.  
 
Research to understand the formation of the granuloma and its impact has been 
carried out for decades using different in vivo and in vitro models. Although the 
whole picture is still vague, some parts have been well established. As a 
Fig. 1.5 Progression of the human tuberculosis granuloma (Russell, 2007; 
Russell et al., 2009). 
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proinflammatory response, many cytokines and chemokines are involved, such as 
TNF (tumor necrosis factor) (Algood et al., 2005; Saunders & Britton, 2007) and 
IFN-γ (Cooper et al., 1993; Pearl et al., 2001). 
1.5 Mycobacterial cell wall  
Mycobacteria are classified as Gram-positive, but have an unusual and distinct 
lipid-rich cell wall. The mycobacterial cell wall functions as a permeability barrier for 
many molecules, including many antibiotics (Brennan & Nikaido, 1995). It also 
provides a physical protection that helps the bacteria survive from the hash 
environment inside infected macrophages (Wang et al., 2000). This atypical cell wall 
confers a characteristic acid-fast staining property to the bacteria; cells stained with a 
primary dye (basic fuschin) are resistant to acid-alcohol decolourisation (Brennan & 
Nikaido, 1995; Danilchanka et al., 2008). Additionally, in pathogenic mycobacteria, 
due to its location as the outermost component, the cell wall also interacts with the 
host cell and is involved in immune modulation and virulence (Cox et al., 1999; 
Kan-Sutton et al., 2009; Strohmeier & Fenton, 1999). The cell wall biosynthetic 
pathways have been targets for several anti-mycobacterial drugs too. INH targets 
enoyl-ACP reductase (InhA) in mycolic acid biosynthesis (Rozwarski et al., 1998; 
White et al., 2005) and EMB targets an arabinosyltransferase involved in cell wall 
arabinan biosynthesis (Belanger et al., 1996; Telenti et al., 1997). Therefore, a good 
understanding of the structure and biosynthesis of the cell wall will help give clues 
not only to the development of novel anti-mycobacterial drug targets, but also further 
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our understanding of Mycobacterium-host cell interactions. The various components 
of the mycobacterial cell wall are shown in Fig. 1.6.  
 
1.5.1 Peptidoglycan (PG):  
The peptidoglycan (PG) of mycobacteria is similar to that of other bacteria, 
consisting of β-(1,4) linked N-acetylglucosamine (NAG), N-acetylmuramic acid 
(NAM) residues, and a tetra-peptide chain. The tetra-peptide chain usually includes 
L/D-alanine, D-isoglutamine and meso-diaminopimelic (mDAP), and can be 
cross-linked to form a three dimensional mesh-like layer (Madigan & Martinko, 2005). 
In Mycobacterium, the cross-link occurs between two mDAP residues or between 
Fig. 1.6 Schematic representation of the mycobacterial cell wall (Dover et al., 2004). 
Burgundy, peptidoglycan (PG); yellow, galactan domains of mycolylarabinogalactan 
(mAGP) ; turquoise, arabinan of mAGP; black, mycolic acid residues of mAGP; green, 
trehalose mono- and dimycolates (TMM and TDM); orange, a diverse repertoire of 
complex lipids. 
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mDAP and D-alanine (Brennan, 2003; Lavollay et al., 2008). The biosynthesis of PG 
is well defined in Escherichia coli and the biosynthetic process is considered to be 
similar between the two species (Goffin & Ghuysen, 2002; van Heijenoort, 2001).  
1.5.2 Arabinogalactan (AG):  
Situated immediately outside the PG, the arabinogalactan (AG) layer is a 
branched polymer of galactose and arabinose. The galactose containing non-reducing 
end of AG is covalently bound to the NAG residue of PG by a unique linker, a 
disaccharide bridge α-L-Rhap-(1→3)-D-GlcNAc-(1→P) (McNeil et al., 1990). AG 
biosynthesis is essential for the growth and survival of mycobacteria. AG has a linear 
galactan chain of about 30 β-D-galactofuranose (β-D-Galf) residues which is further 
elaborated by arabinan chains. The arabinan chain is composed of linear 
(1→5)-α-D-arabinfuranosyl (α-D-Araf) residues and branches to form a 3,5-α-D-Araf 
linked fork (Alderwick et al., 2007; Besra et al., 1995; Daffe et al., 1990). In addition, 
almost two-thirds of the arabinan chains are esterified with mycolic acids at the 
non-reducing termini of the arabinan chain (Daffe et al., 1990). The entire complex, 
encompassing PG and AG are esterified with mycolic acids, is also known as the 
mycolyl-arabinogalactan-peptidoglycan (mAGP) complex.  
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1.5.3 Membrane bound lipoglycans and glycophospholipids: 
LAM, together with its precursors, lipomannan (LM) and PIMs are major 
lipoglycans found in the mycobacterial cell wall. They are important not only for the 
structure of the cell wall but also for modulating the host response during infection. 
Core structures are shown in Fig. 1.7 (Guerardel et al., 2003).  
All lipoglycans contain a phosphatidyl-myo-inositol moiety (PI anchor), which is 
acylated. The acyl chains insert into the cell membrane, attaching the molecule 
directly to the membrane (Brennan & Besra, 1997; Hunter & Brennan, 1990). A 
previous study revealed that the PI anchor in LAM derived from M. bovis BCG plays 
Fig. 1.7 General structure of ManLAM from M. tuberculosis and structural relationship 
between PIMs, LM and LAM (Guerardel et al., 2003). 
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an important role in stimulating cytokine secretion of human DCs (Nigou et al., 1997). 
Structural analysis shows that the O-3 position of the myo-inositol unit can also be 
acylated with fatty acids (Hsu et al., 2007). The smallest lipoglycan precursor is PIM1 
which has a mannose residue attached to the 2-position of the myo-inositol ring of the 
PI anchor which can be further acylated at the 6-position of the mannose residue (Hsu 
et al., 2007; Kordulakova et al., 2003). Addition of another mannose residue to the 
6-position of the myo-inositol ring of the PIM1 results in the formation of PIM2. 
Primed from the second mannose, the molecule can be elongated up to five mannose 
residues at position-6 to form PIM6 (Briken et al., 2004). LM from most mycobacteria 
including M. tuberculosis possesses an α(1→6)-linked mannan backbone extended 
from PIMs with α(1→2) substitution of single mannose, while Mycobacterium. 
chelonae posesses α(1→3) substitution of single mannose residues (Guerardel et al., 
2002). LAM, based on the structure of LM, has a branched arabinan polymer attached 
to the mannan, which is further decorated by terminal mannose caps (Nigou et al., 
2003). It can be classified into three groups based on the capping motif: 
mannose-capped LAM (ManLAM), in pathogenic strains such as M. tuberculosis, has 
caps for single, di- or tri-mannosides (Chatterjee & Khoo, 2001; Guerardel et al., 
2003); inositol phosphate-capped LAM (PILAM), found in the fast-growing 
non-pathogenic strains such as M. smegmatis, has inositol phosphate caps (Khoo et al., 
1995); AraLAM, found in M.chelonae, has neither mannose caps or inositol 
phosphate caps (Guerardel et al., 2002; Guerardel et al., 2003).  
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1.5.4 Mycolic acids:  
 Mycolic acids are one of the major components of the cell wall and can be found 
attached either to AG or as components of other free lipids, such as trehalose 
monomycolates (TMM) and dimycolates (TDM), and glucose monomycolate (GMM). 
Mycolic acids are long chain β-hydroxy-α-alkyl fatty acids. They consist of a long 
mero-chain (> C50, various in different species) and a saturated α-chain (C24-C26) 
(Brennan & Nikaido, 1995). The mero-chain can be modified with different 
functional units, such as double bonds, methoxy or keto groups, 
cis/trans-cyclopropanations and epoxidations (Barry et al., 1998), which vary in 
different species (Fig. 1.8 and Table 1.2). 
Fig. 1.8 Representative structures of mycolic acids (Barry et al., 1998). A. Some 
representative examples of α- and α’- mycolic acids, lacking oxygen functions in addition to 
the 3-hydroxy acid unit. B. Oxygenated mycolic acids, M-methoxy, K-keto, W-wax ester, 
E-epoxy, ω-1 M-ω-1 methoxy. 
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Table 1.2 Variation of mycolic acid classes in Mycobacterium species 
Mycolic Acid Classes 
Species α* α' M K E W 
M. tuberculosis +  + +   
M. bovis +  + +   
BCG +  + +   
M. avium +   +  + 
M. smegmatis + +   +  
M. kansasii +  + +   
M. marinum +   + +     
*α and α’ lacking oxygen functions in addition to the 3-hydroxy acid unit, M-methoxy, K-keto, 
E-epoxy, W-wax ester (Barry et al., 1998)  
The structure of mycolic acids also relate to the function of these lipids. Small 
changes in the structure can have profound effects on the biology of the bacilli 
(Dubnau et al., 2000; Ueda et al., 2001). For example, cyclopropanation of mycolic 
acids is essential for cord formation and virulence (Glickman et al., 2000). 
Cis-cyclopropane modification can help bacteria with early growth in macrophages 
(Rao et al., 2005); and trans-cyclopropane modification shows suppressive effects on 
M. tuberculosis-induced inflammation and virulence (Rao et al., 2006) .  
1.5.5. Intercalation of free-outer lipids: 
As mentioned above, the mycobacterial cell envelope is intercalated with various 
‘free’ glycolipids that are attached to the mAGP complex through hydrophobic 
interactions. This glycolipid-rich outer layer is composed of PDIMs, PGLs, mycolic 
acid containing lipids (TMM, TDM and GMM) and other kinds of complex lipids, 
such as glycopeptidolipids (GPLs) and lipooligosaccharides (LOSs). 
 
Chapter 1 General Introduction 
 24
i. Phthiocerol dimycocerosate (PDIM): 
PDIM is composed of a long-chain phthiocerol or phthiodiolone di-esterified with 
multimethyl-branched long-chain mycocerosic acids (Minnikin et al., 2002). PDIM 
deficiency causes attenuation of virulent strains in mice (Camacho et al., 2001; Cox et 
al., 1999; Simeone et al., 2007). It participates in the early stage of M. tuberculosis 
infection with macrophages, including receptor-dependent phagocytosis, phagosome 
acidification arrest, protection of bacilli from reactive nitrogen intermediates and also 
modification of host cell membranes (Astarie-Dequeker et al., 2009; Rousseau et al., 
2004). In addition, PDIM biosynthesis can be negatively selected under laboratory 
conditions (Domenech & Reed, 2009).  
ii. Phenolic glycolipid (PGL):  
PGL was originally termed as a type of “mycoside” in mycobacteria 
(Gastambide-Odier et al., 1967) and was only observed in slow growing pathogenic 
strains, such as M. kansasii, M. gastri, M. ulcerans, M. leprae, M. marinum and M. 
tuberculosis (Daffe & Laneelle, 1988). PGL and PDIM share a similar lipid structure, 
whilst PGL has a glycosylated phenolic moiety at the end of the phthiocerol chain. 
PGL has been reported with various immunomodulatory properties (Fournie et al., 
1989; Prasad et al., 1987; Vachula et al., 1989), for example inhibiting the release of 
proimmflamatory chemokines and cytokines (Reed et al., 2004). The deficiency of 
PGL production can lead to attenuation in virulence of M. bovis in a Guinea pig 
infection model (Collins et al., 2005).  
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iii. Mycolic acid containing glycolipids: 
TDM, also known as cord factor, contributes not only to the cord-like serpentine 
growth characteristics of M. tuberculosis but also to virulence (Ryll et al., 2001). 
Purified TDM induces a wide range of chemokines and cytokines which contributes 
to its immunomodifying function (Lima et al., 2001). TDM can help the bacilli to 
enter macrophages (Yasuda, 1999) and induce the formation of granulomas (Behling 
et al., 1993; Borders et al., 2005; Guidry et al., 2007). As a structural component of 
TDM, mycolic acids with different modifications and chain lengths can impact on the 
toxicity and other biological functions of TDM (Dubnau et al., 2000; Fujita et al., 
2007). Besides, TDM shows diverse immunologic activities like adjuvant and 
antitumor properties (Silva et al., 1985). TMM is a precursor in TDM biosynthesis 
and plays a role in the transfer of mycolic acids onto the cell wall AG (Belisle et al., 
1997; Katsube et al., 2007). GMM is synthesised by using host-derived glucose and 
can be an indicator of infection. GMM can be recognised by CD1-T cells and mediate 
a T cell response (Enomoto et al., 2005; Moody et al., 1997). 
iv. Sulfolipid (SL):  
SL is a glycolipid composed of a trehalose 2-sulfate core modified with four fatty 
acyl substituents (Goren et al., 1976). It is found in some virulent strains of M. 
tuberculosis, although its function remains unclear. For example, it is reported that SL 
can block the release of reactive oxygen and enhance the secretion of IL-8 and TNF-α 
in phorbol myristate acetate (PMA)-stimulated macrophages (Brozna et al., 1991). 
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More recent studies with SL have shown its inhibitory effect on TDM induced TNF-α 
secretion in macrophages and granuloma formation in mice (Okamoto et al., 2006). In 
addition, the loss of SL shows no impact on bacilli replication in a mouse model of 
infection (Kumar et al., 2007).  
v. Glycopeptidolipids (GPLs):  
GPLs are a major constituent of the outer layer cell wall of several species of 
non-tuberculosis Mycobacterium including the saprophytic M. smegmatis and the 
opportunistic pathogen Mycobacterum avium. A common structure of fatty 
acyl-tetrapeptide (FATP) are shared between GPLs, while the glycosylations are 
different between non-pathogenic and pathogenic mycobacteria (Chatterjee & Khoo, 
2001; Patterson et al., 2000). In non-serovar-specific GPLs (nsGPLs) from 
non-pathogenic Mycobacterium, such as M. smegmatis, the FATP is modified with 
6-deoxytalose (6-d-Tal) at the threonine residue and O-Me-Rha (O-methyl-rhamnose) 
at the L-alaninol residue. In serovar-specific GPLs (ssGPLs) from pathogenic 
mycobacteria, such as M. avium, more complicated glycosylations are found based on 
the structure of nsGPLs (Aspinall et al., 1995; Belisle et al., 1993). Although, ssGPLs 
are from non-tuberculosis Mycobacterium, their virulence-related and 
immunomodulating properties have been identified (Barrow et al., 1995; Krzywinska 
et al., 2005; Sweet & Schorey, 2006; Torrelles et al., 2002). Recently, it was reported 
that GPLs from M. smegmatis participate in receptor-dependent phagocytosis of 
Mycobacterium by macrophages (Villeneuve et al., 2005), and M. avium-GPLs core 
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antigen can be used for the clinical serodiagnosis of pulmonary M. avium disease 
(Kitada et al., 2005; Kitada et al., 2008).  
vi. Lipooligosaccharides (LOSs): 
 LOSs can be found in M. kansasii, M. gastri, M. marinum and the Canetti variant 
of M. tuberculosis (Burguiere et al., 2005b; Daffe et al., 1991b; Gilleron & Puzo, 
1995). LOSs are highly antigenic glycoconjugates on the cell surface and are used as 
targets for serotyping. It has been reported that LOSs are involved in biofilm 
formation and infection of macrophages in M. marinum (Ren et al., 2007). Recently 
several genes have been identified involved in LOS biosynthetic (Burguiere et al., 
2005b; Etienne et al., 2009; Ren et al., 2007). However, little is known about the 
biosynthesis and function of LOSs. 
1.6 Surrogate systems for TB research 
Although much effort has been made to understand the mechanism of 
pathogenesis for the discovery of novel drugs and development of better vaccines, 
there are still several problems associated with M. tuberculosis research. Firstly, M. 
tuberculosis grows very slowly and the average generation time is about 20 hours. 
Secondly, since M. tuberculosis is an airborne human pathogen it has to be handled in 
a Biosafety Level 3 (BSL-3) laboratory. Thirdly, genetic manipulation, till recently, 
has been lagging behind due to lack of available genetic tools. To overcome these 
problems, a number of other Mycobacterium and related species have been used as 
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surrogate models to study TB. Furthermore, the whole genome information of M. 
tuberculosis was released in 1998, with the size of 4.4Mb and about 4000 open 
reading frames (Camus et al., 2002; Cole et al., 1998). Later, when more 
mycobacterial species have also been sequenced, it will be possible to compare 
genomes between M. tuberculosis and surrogate systems to help better understand the 
mechanism of M. tuberculosis virulence and choose the right surrogate system for 
certain studies. 
1.6.1 Corynebacterium glutamicum 
C. glutamicum is non-pathogenic and is classified into Corynebacterineae of the 
Actinobacteria phylum, and is thus closely related to M. tuberculosis. C. glutamicum 
has been used industrially for amino acid production (Kinoshita, 1985). It has a 
distinct lipid rich cell wall, similar to M. tuberculosis with mAGP (Dover et al., 2004) 
but simpler than M. tuberculosis. The genome sequencing of C. glutamicum was 
completed in 2003, showing a genome half the size of M. tuberculosis and less 
paralogous genes in the C. glutamicum genome (Kalinowski et al., 2003). Although C. 
glutamicum shows a broad metabolic diversity, compared to M. tuberculosis, it is used 
as a model system for mycobacterial cell wall biosynthesis studies (De Sousa-D'Auria 
et al., 2003; Gande et al., 2004; Gibson et al., 2003). This is because of its better 
tolerance to the deletion of genes whose homologues are essential in M. tuberculosis, 
such as Cg-emb (Seidel et al., 2007).  
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1.6.2 M. smegmatis  
M. smegmatis is non-pathogenic and fast-growing, with an average generation 
time of about 4-5 hours, and thus overcomes the two major hurdles of working with M. 
tuberculosis. While M. smegmatis makes some lipids that are different, most cell wall 
components like PG, AG and mycolic acids are common to both species. M. 
smegmatis can tolerate mutations altering cell wall biosynthesis better than M. 
tuberculosis, for example, embC and aftC can be deleted in M. smegmatis but not in 
M. tuberculosis (Birch et al., 2010). The size of M. smegmatis genome is 7.0 Mb, 
larger than that of M. tuberculosis, and it shows high genomic divergence in that only 
69.8% of the protein-coding genes of M. tuberculosis have been found with 
orthologues in M. smegmatis (Altaf et al., 2010). Given its non-pathogenicity, M. 
smegmatis has limited use as surrogate model for virulence studies and is usually 
restricted to the study of metabolic processes. However, it is still a useful system for 
cell wall biosynthesis, because it can easily be genetically manipulated compared to 
M. tuberculosis. The most popular M. smegmatis strain used in TB research is M. 
smegmatis mc2155, which originated from M. smegmatis ATCC 607 (Snapper et al., 
1990). It shows a high efficiency in plasmid transformation (electroporation), which is 
invaluable in the analysis of mycobacterial gene function, expression and replication. 
1.6.3 Mycobacterium marinum  
M. marinum is a fish pathogen and can also cause lesions on human skin 
(Wolinsky, 1992). It grows faster than M. tuberculosis with an average generation 
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time of 4 hours under a optimal growth temperature of 25°C to 35°C (Clark & 
Shepard, 1963). Additionally, M. marinum can be handled in a BSL-2 laboratory. The 
size of the M. marinum genome is 6.6Mb, about 1.5 times the size of M. tuberculosis. 
M. marinum shares 85% identity to the orthologous regions of M. tuberculosis 
(Stinear et al., 2008). The cell wall lipids of M. marinum are related to those of M. 
tuberculosis, except for the altered stereochemistry of PDIM components (Onwueme 
et al., 2005). Thus, while M. marinum has most of the advantages of M. smegmatis, it 
can also be evaluated for virulence, as it is a pathogenic Mycobacterium, without the 
need for BSL-3 containment. Another advantage of M. marinum is that it can be used 
to study the pathogen-host interaction using zebrafish model as the host (Pozos & 
Ramakrishnan, 2004; Stamm & Brown, 2004). Zebrafish are one of the natural hosts 
of M. marinum and infected zebrafish can develop granulomas, a key feature of TB 
infection in humans (Prouty et al., 2003; Tobin & Ramakrishnan, 2008). Although the 
fish immune system is still not fully understood, zebrafish have both innate and 
adaptive immune systems (Traver et al., 2003) and the outcome of infection, acute or 
chronic, depends on the infection dose (Prouty et al., 2003). There are several other 
advantages of the zebrafish model, such as transparent fish embryos allow real-time 
analysis by using fluorescent labeled M. marinum (Davis et al., 2002). 
1.7 Molecular genetic tools in TB research 
To control TB, a better understanding of mycobacteria, the bacilli itself and its 
interaction with host as well, is very important. Genetic manipulations of the genome, 
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such as gene knock-outs, introduction of other genes, or the generation of random 
Tn-mutant libraries, are very powerful methods. Although genetic tools used in 
mycobacteria are less well developed compared with those in other species, such as E. 
coli, much progress has been made in past 30 years, especially after the release of the 
complete genome sequence of M. tuberculosis.  
1.7.1 Plasmid 
A plasmid is a DNA molecule outside the bacterial chromosome and can replicate 
independently. It plays an important role in bacterial biology. Several Mycobacterium 
species have been found containing naturally occurring plasmids, for instance the 
MAIS complex (M. avium, Mycobacterium intracellulare, Mycobacterium 
scrofulaceum) and Mycobacterium fortuitum (Crawford & Bates, 1979; Crawford & 
Bates, 1986). A small plasmid has been found in the widely used M. smegmatis 
mc2155 strain (Beggs et al., 1995), although its original strain, M. smegmatis 
ATCC607, shows no sign of a plasmid (Crawford et al., 1981). Conversely, M. 
tuberculosis do not possess a plasmid (Zainuddin & Dale, 1990). Naturally occurring 
plasmids in mycobacteria are considered to correlate with virulence (Gangadharam et 
al., 1988; Mizuguchi et al., 1981). For example, M. ulcerans, the causative agent of 
the devastating skin disease, Buruli ulcer, contains a 174-kb plasmid (pMUM001) 
bearing a cluster of genes responsible for the biosynthesis of a macrolide toxin, which 
is cytotoxic and immunesupressive and can cause massive tissue damage (Stinear et 
al., 2004). 
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As a genetic tool, plasmids are used to multiply gene copies or to express proteins 
for functional studies. Plasmids isolated from mycobacteria are very helpful for 
developing vectors for genetic manipulation in mycobacteria. Plasmid pAL5000, 
recovered from M. fortuitum (Labidi et al., 1985), is the most widely used replicon in 
many Mycobacterium species. Thus, many currently used mycobacterial vectors are 
developed on pAL5000. Shuttle plasmids made by cloning pAL5000 into E. coli 
plasmids can replicate in not only fast-growing mycobacteria but also slow-growing 
mycobacteria, including M. bovis BCG and M. tuberculosis (Ainsa et al., 1996; Garbe 
et al., 1994; Snapper et al., 1988). Later, with the understanding of their replication 
mechanisms, small fragments with only genes essential for replication in 
Mycobacterium are used as vectors. An example is pMV206 carrying only orf1, orf2 
and part of orf5, from which derived pMV261 with the M. bovis BCG hsp60 promoter, 
to help the expression of foreign proteins in mycobacteria (Stover et al., 1991). 
Derivatives of pAL5000 are applied to general cloning, reporter genes, delivery 
systems and protein expression. Shuttle vectors derived from pAL5000 maintain low 
copy in Mycobacterium (Stolt & Stoker, 1996; Stover et al., 1991) with 2-5 copies per 
cell and E. coli is used as an intermediate host for DNA manipulation. Besides 
pAL5000, other naturally occurring plasmids are also used for vector construction, 
such as pMSC262 from M. scrofulaceum (Qin et al., 1994). To avoid possible effects 
in phenotype caused by gene over expression, sometimes an integration system is 
utilised. Vectors carrying L5 phage integrase were later developed as pMV361 which 
is a derivative of pMV261 (Stover et al., 1991). 
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1.7.2 Transposon 
A transposable element is a DNA fragment that can move from one position in 
the genome to another independently. They are found widely in prokaryotes and 
eukaryotes. About 50 transposable elements have already been discovered in several 
Mycobacterium species based on sequence similarity, and most of them are host 
restricted and inactivated (Hatfull & Jacobs, 2000).  
Transposition can cause different genetic rearrangements among which 
interruption of the gene in the transposition site is the most common. According to 
this, transposable element- based genetic tools were developed. As a class II 
transposable element, transposon (Tn) is composed of a transposition essential 
element (invert repeat sequence, transposase and resolvase) and genes not required for 
transposition, such as an antibiotic resistant gene. Thus Tn can be used for functional 
studies by either insertion mutagenesis or by activation through induction of promoter 
and protein expression under certain conditions by adding promoterless reporter genes. 
There are two kinds of Tn used in TB research, Tn derived from naturally occurring 
mycobacterial transposon elements and from mariner transposon elements. Since 
there are six activate insertion sequences (ISs) in Mycobacterium, Tn were developed 
based on them, such as Tn61i from IS6100 (Martin et al., 1990) and Tn5370 from 
IS1096 (Cox et al., 1999). The horn fly Haematobia irritans original mariner 
transposable element belongs to a superfamily whose members can be found in a wide 
range of eukaryotic hosts. It can be used in both E. coli and M. smegmatis (Rubin et 
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al., 1999).  
1.7.3 Delivery systems for mutagenesis 
Random Tn mutagenesis and specialised mutagenesis are two useful methods. In 
case of mycobacteria, especially for slow growing mycobacteria, because of the 
frequency of transposition is very low, to get enough random mutants, a large amount 
cells with DNA transferred are necessary. Similarly, to obtain a specific knock-out 
mutant, a large amount cells with DNA transferred can increase the odds of successful 
homologous recombination. Therefore, an efficient delivery system is critical for 
successful mutagenesis (Pelicic et al., 1997). In mycobacteria mutagenesis, two 
delivery systems are most often used, temperature-sensitive plasmid and phage 
(Hatfull & Jacobs, 2000).  
Temperature-sensitive plasmids are plasmids that can replicate at 30°C to 32°C 
but not at 39°C to 40°C. The first themosensitive plasmid used in mycobacteria was 
derived from pAL5000 and tested in M. smegmatis (Guilhot et al., 1992). Further, by 
carrying a Tn, it has succeeded in Tn-mutagenesis (Perez et al., 1998). Later two 
modified plasmids were constructed based on this, pPR27 and pPR23, with a SacB 
gene, for use in slow growing mycobacteria. SacB encodes a levan sucrase, which is 
lethal to mycobacteria if sucrose is added to the media. It provides a counter-selection 
for mutagenesis in addition to temperature pressure (Pelicic et al., 1997).  
Phage is a bacterial virus and it infects host cells via a receptor-dependent process. 
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Phage can also specifically infect mycobacteria. Due to high infection efficiency, it 
has been used as a delivery system. A random library of phage genome was 
constructed into an E. coli as plasmid and selected for the chimeric molecule that 
could replicate in E. coli as a plasmid and infect mycobacterial cells as a phage 
(Jacobs et al., 1989a; Jacobs et al., 1989b). The final molecule was termed phasmid. 
Later, a temperature-sensitive shuttle phasmid system was developed, phAE70 
derived from D29 mycabacteriophage and phAE87 from TM4 (Bardarov et al., 1997). 
It can be manipulated as plasmid or cosmid in E. coli and replicate as a lytic phage in 
mycobacteria at the permissive temperature, while it can only infect mycobacteria but 
not form plaques at the non-permissive temperature.  
1.9 Aims and objectives 
The main objective of my studies is to study cell wall biosynthesis in 
mycobacteria. Considering the advantages and disadvantages of different models in 
TB research, I plan to use M. smegmatis and M. marinum as models to isolate mutants 
of each species that are defective in the biosynthesis of the mycobacterial cell wall 
with the aim of identifying genes involved in its synthesis. There are three genetic 
strategies that have been used to study cell wall biosynthetic pathways. 
The first is specialised knock-out, generating mutants of specific genes in 
surrogate systems and complementing the mutants with the gene and also its M. 
tuberculosis homologue, for functional studies. As mentioned above, due to the 
difficulties of genetic manipulation in M. tuberculosis, surrogate systems are widely 
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used to study cell wall biosynthesis in Mycobacterium. For instance, aftA which is 
involved in AG biosynthesis in M. tuberculosis was identified using bioinformatics 
analysis and later confirmed by complementing the mutant in C. glutamicum with the 
M. tuberculosis orthologue (Alderwick et al., 2006). Similarly, the function of aftC of 
M. tuberculosis in LAM biosynthesis was also confirmed in M. smegmatis (Birch et 
al., 2010).  
Another strategy is to screen for mutants with morphology changes from random 
Tn-mutant libraries. From previous studies, it is known that the disruption of genes 
involved in the biosynthesis or the transportation of cell wall components, usually 
results in an altered physical morphology. For example, deletion of kasB, responsible 
for elongation of mycolic acids, results in a small colony morphology in M. 
tuberculosis (Bhatt et al., 2007). Dysfunction of pcaA, a gene responsible for 
cyclopropane ring synthesis of mycolic acids, causes no cording forming and fails to 
persist in infected mice (Glickman et al., 2000). Inactivation of pstA in M. avium 
leads to the loss of a specific lipopeptide and an inability to form biofilms (Wu et al., 
2009). Thus, it is assumed that a morphology change can vice versa indicate changes 
in cell wall components. 
Finally, based on the generation of a Tn-mutant library, screening for 
mycobacteriophage-resistant mutants was also developed as a tool. 
Mycobacteriophages can infect host cells by attaching to specific cell surface receptor 
molecules, e.g. proteins, glycans or lipids. These receptors would be expected to be 
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the outermost components of the mycobacterial cell wall. Thus, any changes in those 
surface molecules may cause resistance to phages. For example, two phage resistant 
mutants of M. smegmatis result in structural changes of acyltrehalose-containing 
lipooligosaccharides (Dao et al., 2008). The difference in phage sensitivity can be 
caused by the disruption of host genes involved in phage infection processes, one of 
which associates with the receptor on cell wall. Therefore phage sensitivity can also 
be used to study cell wall biosynthesis.  
In this study, the last two strategies will be utilised and the aims are as follows: 
1. To generate a Tn-mutant library of M. smegmatis mc2155 and M. marinum 1218R 
(ATCC 927). 
2. To screen for mutants based on colony morphology changes on different agar 
media and phage-sensitivity. 
3. To biochemical characterise selected mutants by lipid analysis and 
complementation experiments. 
4. To examine the virulence of M. marinum mutants in vitro in murine bone marrow 
derived macrophages and the zebrafish model of infection. 
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2.1 Introduction 
As outlined in Chapter 1, the mycobacterial cell wall is made up of complex 
lipids and carbohydrates that play important roles in determining permeability and 
virulence (Aspinall et al., 1995; Cox et al., 1999). Our understanding of the 
mycobacterial cell wall structure is evolving along with advances in the analysis 
techniques for observing the physical structure of the cell wall. Minnikin first 
proposed in 1982 that the mycobacterial cell envelope was an asymmetric structure, 
with the inner layer formed by the cell membrane, PG and AG-attached mycolic acids, 
with the outer layer consisting of ‘free’ lipids intercalated within the AG-attached 
mycolate layer (Minnikin, 1982). Further, X-ray diffraction studies by Nikaido 
revealed that mycolic acids were stacked parallel to each other and perpendicular to 
the cell membrane (Nikaido et al., 1993). Much finer details were subsequently 
revealed by cryo-electron tomography that confirmed the multilayer structure of the 
mycobacterial cell wall, but proposed a modified model with an complete coverage of 
mycolic acids and free lipids in the inner layer binding to the cytoplasm membrane 
directly (Hoffmann et al., 2008; Zuber et al., 2008). 
Thus a complex mix of covalent bonds and hydrophobic interactions results in a 
uniquely ‘packed’ cell wall. Any changes in the classical composition of the cell wall 
constituents could impact upon interactions. These alterations often result in changes 
of cell wall structure and as a result in colony morphology. Changes include either a 
complete loss of a cell wall component (Kan-Sutton et al., 2009) or the accumulation 
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of an intermediate with altered structure (Ren et al., 2007). For example, (i) a 
deficiency in elongation of mycolic acids caused by the deletion of kasB resulted in 
small colonies of M. tuberculosis (Bhatt et al., 2007), (ii) the absence of 
cyclopropanation of mycolic acids in M. bovis BCG and M. tuberculosis resulted in 
loss of cord formation (Glickman et al., 2000), (iii) the deletion of a reductase 
responsible for reducing β-oxo acyl intermediates to form mature mycolic acids in M. 
smegmatis, changes the colony morphology from a smooth surface to a dry texture 
(Bhatt et al., 2008), and (iv) the loss of GPLs in either M. smegmatis or M. avium 
leads to a rough colony morphology (Billman-Jacobe et al., 1999; Riviere et al., 
1996).  
The aim of the studies described in this chapter was to generate random 
Tn-mutant libraries of M. smegmatis and M. marinum (two mycobacterial species that 
are used as surrogates to study M. tuberculosis), and to use these as a resource to 
screen for mutants with altered cell walls. Two different, but complementary 
approaches were used to isolate mutants from these two libraries. In one approach, 
Tn-mutant libraries of M. smegmatis and M. marinum were plated onto various agar 
media to isolate Tn-mutants that displayed altered colony morphology. In a second 
parallel approach, the M. smegmatis library was screened for resistance to 
mycobacteriophages. This second screen was based on the hypothesis that the outer 
cell wall components would also be receptors for mycobacteriophages and that loss of 
a specific receptor (due to a Tn insertion in one of its biosynthetic genes) would result 
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in resistance to the mycobacteriophage. The results obtained from this second screen 
are discussed separately in Chapter 3.  
Tn-mutagenesis has been a powerful tool for studying different aspects of M. 
tuberculosis biology. It has been used to identify metabolic pathways and virulence 
factors (Guilhot et al., 1994; Kleckner et al., 1991; McAdam et al., 2002) as well as to 
provide information for global screens to predict essential genes in genomes of 
mycobacteria (Lamichhane et al., 2003; Sassetti et al., 2001). Although Tns derived 
from naturally occurring insertion sequences (ISs) in mycobacterial genomes have 
often been used for mutagenesis (Cirillo et al., 1991; Martin et al., 1990; McAdam et 
al., 1995), more recently a mariner-based Tn, which is derived from a Tn  in the horn 
fly Haematobia irritans has been used for Tn mutagenesis in both fast-growing and 
slow-growing mycobacteria (Rubin et al., 1999; Rybniker et al., 2003; Sassetti et al., 
2001). Mariner-based Tns offer the advantage of being non-indigenous (no 
homologous recombination with IS insertion) and having a high transposition 
frequency. In addition, the efficiency of Tn-mutagenesis has been improved by the use 
of a temperature sensitive phage delivery systems (Bardarov et al., 1997; Rybniker et 
al., 2003). 
In this study, phAE181, a recombinant phage that contains a derivative of the 
mariner-based Tn5371 was used. The recombinant phage phAE181 is derived from a 
temperature sensitive mutant of the lytic mycobacteriophage TM4, which can infect 
many slow and fast growing Mycobacterium species, including M. tuberculosis, M. 
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smegmatis and M. marinum. The phage can replicate inside a mycobacterial host 
(with a productive lytic cycle) at 30°C, but not at the non-permissive temperature of 
37°C. Tn5371, which contains a hygromycin resistance gene (hyg), can thus be 
delivered by infecting the target Mycobacterium host at 37°C, followed by selection 
of Tn-mutants on hygromycin-containing plates at 37°C. Tn5371 mutagenesis 
libraries were generated for M. smegmatis and for M. marinum using phAE181 and 
the data included in this chapter describe the isolation and identification of M. 
smegmatis and M. marinum Tn-mutants with altered colony morphology.  
2.2 Materials and Methods 
2.2.1 Bacterial strains, phages and growth conditions 
Bacterial strains, plasmids, and phages used in this study are listed in Table 2.1. 
M. smegmatis was grown in TSB at 37°C and M. marinum was grown in 7H9+OADC 
at 30°C, both with 0.05% Tween 80. E. coli was grown in LB broth at 37°C. 
Hygromycin B was added at concentrations of 100μg/ml, 75μg/ml and 150μg/ml, 
respectively, for M. smegmatis, M. marinum and E. coli where required. 
Table 2.1 Phage and bacterial strains used in this study 
Strains and Phage Discription Source or Reference
Phage   
phAE181 
Conditionally replicating phage TM4 derivative 
carrying Tn5371 
(Kriakov et al., 2003)
Bacteria   
E. coli cc118λpir   
M. smegmatis mc2155 Parental (wild type strain) strain, Ept mutant  (Snapper et al., 1990)
M. marinum 1218R Parental (wild type strain) strain  ATCC927 
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2.2.2 Generation of high titre phage lysate 
For generating a high titre phage lysate, the titre of an existing phAE181 lysate 
was first checked as follows. First, 200μl of a late log-phase culture of M. smegmatis 
mc2155 was mixed with molten 7H9 soft agar (5ml, 50°C) and overlaid on a basal 
layer of 7H9 agar in a petri-dish and the agar was allowed to solidify. In parallel, the 
existing stock of phAE181 was ten-fold serially diluted (10-1-10-10) in MP buffer 
(50mM Tris·HCl pH7.8, 150mM NaCl, 10mM MgSO4, 2mM CaCl2). Then 10μl of 
the dilutions were spotted on the overlay of M. smegmatis mc2155. Plates were 
incubated at 30°C for 2-3 days till plaques were observed on a lawn of M. smegmatis 
mc2155. The plaque forming units (pfu) were counted and phage titre was calculated 
according to the dilution (pfu/ml=number of pfu in spot×dilution factor×100). To 
prepare the high titre lysate, the phage suspension was diluted to obtain an estimated 
500-1000 pfu per plate and mixed with 200μl of late log-phase M. smegmatis mc2155 
culture and molten 7H9 soft agar overlaid on 7H9 agar. Plates were incubated at 30°C 
for 2-3 days to obtain plaques in a lacy pattern. MP buffer (4-5 ml) was added to each 
plate and plates were left at 4°C overnight. The phage soaked buffer was then 
collected and filtered through a 0.45μm filter to obtain the phage lysate. Phage lysate 
was kept at 4°C and the titre was checked as described above. The optimal titre 
required for transduction was 10
10
pfu/ml (Stover et al., 1991). 
2.2.3 Transposon mutagenesis  
M. smegmatis or M. marinum cultures were grown in 50ml of TSB (0.05% Tween 
Chapter 3 Use of Mycobacteriophage Resistant Strains to Identify Cell Wall Biosynthesis Pathways in Mycobacteria 
 44
80) or 7H9+OADC (0.05% Tween 80) to an optical density (OD
600nm
) of 0.8. Cells 
were harvested by centrifugation at room temperature and washed with 50 ml MP 
buffer. Cells were resuspended in 5 ml MP buffer and mixed with high titre phage 
lysate (10
10 to 10
11 pfu/ml) at a multiplicity of infection (MOI) of 10, while 0.5 ml 
cells were mixed with 0.5 ml MP buffer as control. After incubation at 37°C for 1 
hour static culture, cells were harvested and resuspended in 25 ml TSB with 0.05% 
Tween 80 (for M. marinum, 7H9 broth with 0.05% Tween 80). Cells were recovered 
at 37°C overnight before being plated on TSB agar plates with 100μg/ml hygromycin 
B (for M. marinum, 7H10 agar plates with 75μg/ml hygromycin B were used). Plates 
were incubated at 37°C for either 3 to 4 days for M. smegmatis or 2 weeks for M. 
marinum. 
2.2.4 Isolation and sequencing of Tn insertion sites 
Genomic DNA was digested with BssHII (NEB) and ligated with T4 ligase 
(NEB). To select for self-ligated fragments of genomic DNA containing Tn5371 
(containing hyg and the R6K ori) the ligation mix was transformed into E. coli 
cc118λpir. HygR colonies were grown up in LB with hygromycin to obtain plasmid 
DNA. Plasmid DNA isolated from HygR transformants was then sequenced using the 
primers marinerKM (5’-GCTTACAATTTAGGTGGCACT-3’) and marinerHyg 
(5’-TAGACAGATCGCTGAGATAGG-3’) to obtain sequences of the left or right 
regions flanking the Tn insertion.  
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2.3 Results 
2.3.1 Isolation of M. smegmatis Tn-mutants with altered colony morphology and 
phage-resistance 
A total of 715 M. smegmatis strains with Tn insertions were initially inoculated 
into 96-well plates. The cultures were then inoculated using a replicator onto 
rectangular agar media plates. A number of media combinations were used, these 
included TSB, TSB-T (0.05% Tween 80 plus), 7H10, 7H11-T (0.05% Tween 80 plus), 
LB and LB-T (0.05% Tween 80 plus). Eight mutants displayed colony morphology 
changes on at least one of the six agar media compared with wild type strain (Fig. 2.1). 
Under the same growth conditions and similar inoculum volumes, alterations were of 
different kinds, for example, some had smaller zones of growth (1G2 on LB agar), 
while others spread as bigger colonies compared to the wild type strain (2H11 on LB 
agar). Some had smooth surfaces (8D5 on 7H10-T agar), while the wild type strain 
had rough surface (8B7 on TSB-T agar).  
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2.3.2 Isolation of Tn insertion sites and identification of disrupted genes in M. 
smegmatis mutants with altered colony morphology. 
When genomic DNA from a Tn-mutant is digested with BssHII, an enzyme that 
has no sites in Tn3571, one of the genomic BssHII fragments contains the intact 
Tn5371 insertion. When this fragment is circularised by ligation, it replicates as a 
Fig. 2.1 Colony morphology of M. smegmatis Tn-mutants on different media (denoted on the 
left). A. 10μl spot of a stationary phase culture; B. Single colony of each Tn-mutant 
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plasmid (due to the presence of R6K ori) in E. coli cc118λpir. Thus, BssHII digested 
genomic DNA can be added to a ligation reaction and subsequently transformed into 
E. coli cc118λpir to select for Tn-containing recircularised fragments by plating the 
transformants on hygromycin plates. This strategy was used to isolate the Tn-insertion 
as part of a plasmid in E. coli. The isolated plasmids were sequenced using either 
marinerKM (5’-GCTTACAATTTAGGTGGCACT-3’) or marinerHyg 
(5’-TAGACAGATCGCTGAGATAGG-3’). The sequence obtained was then used as 
a query sequence for BLAST (Altschul et al., 1990) to search the Xbase genome 
database (http://xbase.bham.ac.uk/mycodb/).  
As shown in the Table 2.2, amongst the genes that were disrupted by Tn 
insertions in the eight M. smegmatis Tn-mutants with colony morphology changes, 
three were genes in the cell wall and cell processes category, two were genes with a 
role in intermediary metabolism and respiration, two were regulatory genes and one 
was a conserved hypothetical protein with unknown function.  
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Table 2.2 Genes disrupted by Tn insertion in M. smegmatis colony morphology mutants 
Mutant No. Gene No. Gene Name Homologue in M. tuberculosis H37Rv Function 
1G2 MSMEG0031 Penicillin binding protein, 
transpeptidase domain protein
Rv0016c(pbpA) Involved in final stages of 
peptidoglycan synthesis 
2H11 MSMEG0035 FHA domain protein Rv0020c(fhaA): conserved hypothetical 
protein with FHA domain 
Signal transduction 
3D9 MSMEG1654 Isocitrate dehydrogenase, 
NADP-dependent 
Rv0066c(icd2): Probable isocitrate 
dehydrogenase [NADP] Icd2 
Involved in the TCA cycle 
4H5-1 MSMEG3327 Hypothetical protein  Unknown 
6F2 MSMEG5102 ABC transporter 
ATP-binding protein 
Rv1473: Probable macrolide-transport, 
ATP-binding protein ABC transporter 
Involved in active transport 
of macrolide across the 
membrane (export). 
7B3 MSMEG0268 Transcriptional regulator, 
GntR family protein 
Rv0792c: Probable transcriptional 
regulatory protein (probabley 
GntR-family) 
Involved in transcriptional 
mechanism 
8B7 MSMEG4265 MmpS3 protein  Rv2198c(mmpS3): probable conserved 
membrane protein MMPS3 
Unknown 
8D5 MSMEG6756 Glycerol kinase, glpK  Rv3696c(glpK): Probable glycerol kinase 
GlpK 
Key enzyme in the regulation 
of glycerol uptake and 
metabolism 
2.3.3 Isolation of M. marinum Tn-mutants with altered colony morphology. 
Using a similar approach as above, an M. marinum Tn-mutant library was 
screened for mutants with altered colony morphology. In this case, studies were 
limited to 7H10 agar with or without Tween 80 (7H10/7H10 T) due to the inability of 
M. marinum to grow on LB/TSB agar. 
A total of 960 M. marinum Tn-mutants were screened, 23 had colony morphology 
changes either on 7H10 or 7H10 T agar plates compared to the wild type strain (Fig. 
2.2). Under the same growth conditions and similar inoculum volumes, one mutant 
lacked an orange pigment (3E5), some were smaller (8D9-1) or bigger in colony size 
(16F6) and others had different types of colony border/fringes (5G3 and 9D9). 
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2.3.4 Identification of the Tn disrupted genes in M. marinum mutants with 
altered colony morphology 
Using the same strategy that was used for M. smegmatis, the Tn insertions in the 
M. marinum mutants were isolated in E. coli as plasmids and sequenced. The genes 
disrupted in the twenty M. marinum Tn-mutants with colony morphology changes are 
listed in Table 2.3. Amongst the 20 genes, five belonged to the cell wall and cell 
processes category, with only one with known function (MMAR2913,betP, in mutant 
10E9, is a glycine betaine transporter). Amongst the others, one was involved in 
intermediary metabolism and respiration category and seven in lipid metabolism. For 
example mmaA3 in mutant 8G10 is involved in mycolic acid synthesis, whilst ppsB 
and ppsC in mutants 6G3 and 16F6 are involved in PGL and PDIM biosynthesis. The 
remaining disruptions were a putative regulator, a virulence/detoxification/adaptation 
Fig. 2.2 Colony morphology of M. marinum Tn-mutants on 7H10 and 7H10 T agar. 
7H10 T: 7H10 with 0.05% Tween 80 
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related gene and five conserved hypotheticals. 
Table 2.3 Genes disrupted by Tn insertion in M. marinum colony morphology mutants 
Mutant 
No. 
Gene No. Gene Name  Homologue in M. tuberculosis 
H37Rv 
Function 
1G2 MMAR1767 Multifunctional mycocerosic 
acid synthase 
membrane-associated Mas  
Rv2940c(mas): probable 
mulifunctional mycocerosic acid 
synthase membrane-associated 
Mas 
Catalyzes the elongation of N-fatty 
acyl-CoA with 
methylamalonyl-CoA to form 
mycocerosyl lipids 
3E5 MMAR4806 Phytoene dehydrogenase CrtI 
(lipid metabolism) 
Rv3829c: probable 
dehydrogenase 
Function unknown: Probably 
involved in cellular metabolism 
6B11 MMAR5449 EsaT-6 like protein, EsxB Rv3874(esxB): 10 kDa culture 
filtrate antigen EsxB (LHP) 
(CFP10) 
Function unknown 
6G3 MMAR1775  Phenolpthiocerol synthesis 
type-I polyketide synthase 
PpsB 
Rv2932(ppsB): phenolphthiocerol 
synthesis type-I polyketide 
synthase PpsB 
Involved in phenolphthiocerol and 
phthiocerol dimycocerosate (DIM) 
biosynthesis 
7D3 MMAR5440 Hypothetical protein Rv3865: conserved hypothetical 
protein 
Function unknown. 
8D9-1 MMAR4214 Serine protease HtrA (DegP 
protein) 
Rv1223(htrA): probable serine 
protease HtrA (DegP protein) 
Possibly hydrolyzes peptides 
and/or proteins 
8D9-2 MMAR1180  Fatty acyl-AMP ligase 
FadD28_1 and polyketide 
synthase 
Rv1662(pks8): probable 
polyketide synthase Pks8 
Potentially involved in some 
intermediate steps for the synthesis 
of a polyketide molecule  
8G10 Promoter of 
MMAR0978 
Methoxymycolic acid 
synthase 3 
Rv0643c(mmaA3): 
methoxymycolic acid synthase 3 
MMAA3  
Involved in mycolic acid 
modification 
9B4 MMAR5457  ESX-1 secreted protein, EspB Rv3881c: conserved hypothetical 
alanine and glycine rich protein 
Function unknown. 
9D9 MMAR2327  Hypothetical protein Rv1508c: probable membrane 
protein 
Function unknown. 
10C3 MMAR5457  ESX-1 secreted protein, EspB Rv3881c: conserved hypothetical 
alanine and glycine rich protein 
Function unknown. 
10E9 MMAR2913  Glycine betaine transport 
integral membrane protein 
BetP  
Rv0917(betP): possible glycine 
betaine transport integral 
membrane protein BetP 
High-affinity uptake of glycine 
betaine 
10G2 MMAR2341  Fatty acyl-AMP ligase 
FadD25  
Rv1521(fadD25):  probable 
fatty-acid-CoA ligase FadD25  
Involved in lipid degradation. 
11F5 promotor 
region of 
MMAR3235 
Hypothetical protein Rv2191: conserved hypothetical 
protein 
Function unknown. 
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12B4 MMAR0992  Transcriptional regulatory 
protein 
Rv0653c: possible transcriptional 
regulatory protein (probably 
TetR-family) 
Involved in transcription 
mechanism. 
12C3 MMAR5092 Lipoprotein LpqF  Rv3593(lpqF): probable 
conserved lipoprotein, LpqF 
Function unknown. 
13E3 MMAR3223 Hypothetical protein Rv2179c: conserved hypothetical 
protein 
Function unknown. 
14D3 MMAR2352 Hypothetical protein Rv1517: conserved hypothetical 
transmembrane protein 
Function unknown. 
16D10 MMAR3250 Transmembrane protein  Rv2206: probable conserved 
transmembrane protein 
Function unknown. 
16F2 MMAR1774 Phenolpthiocerol synthesis 
type-I polyketide synthase 
PpsC  
Rv2933(ppsC): phenolphthiocerol 
synthesis type-I polyketide 
synthase PpsC 
Involved in phenolphthiocerol and 
phthiocerol dimycocerosate 
biosynthesis 
2.4 Discussion 
According to our hypothesis, inactivation of genes related directly to cell wall 
components, for instance, membrane proteins or lipids, would lead to colony 
morphology changes. In the twenty-eight genes identified from both M. smegmatis 
and M. marinum morphology mutants this was indeed the case; fifteen were annotated 
genes involved in cell wall or cell wall-lipid metabolism. However, six were in 
regulator genes or genes involved in intermediary metabolism and it was likely that 
alterations in the colony morphology were indirect effects. 
In M. smegmatis, eight mutants with colony morphology changes were isolated 
from the Tn-mutant library by using different agar media, either with or without 
Tween 80. Amongst these mutants, two had insertions in a gene cluster associated 
with cell division genes. The mutants 1G2 and 2H11 had insertions in pbpA 
(MSMEG0031) and fhaA (MSMEG0035). The former is a penicillin binding protein 
and a previous report of a M. smegmatis pbpA mutant showed that cells of the 
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knockout strain are longer in shape (Dasgupta et al., 2006). The fhaA gene on the 
other hand encodes a forkhead-associated (FHA) domain protein. The FHA domain 
can recognise phosphothreonine epitopes on proteins which have been found in 
prokaryotic and eukaryotic organisms (Durocher & Jackson, 2002); the 
phosphorylation of proteins is critical for signal transduction. Interestingly, the protein 
kinase pknB is located in the same operon (Fernandez et al., 2006). Thus, the fhaA 
domain protein could be associated with a signalling process in cell division, perhaps 
forming a scaffold for pbpA and other proteins. Although both pbpA and fhaA mutants 
had morphology changes, there were differences between them which indicated 
different functions had been inactivated. Thus, the observed morphology changes 
were likely due to attended cell division patterns. Another mutant with altered colony 
morphology was GntR (MSMEG0268), a regulatory protein. This gene was named 
after the Bacillus subtilis transcription regulator, a repressor of the gluconate operon 
(Haydon & Guest, 1991). According to sequence analysis, GntR (MSMEG0268) 
belongs to the HutC-like regulator sub-family and this sub-family had been reported 
to respond to a number of molecules including long chain fatty acids and trehalose 
6-phosphate (Allison & Phillips, 1990; Matthijs et al., 2000; Quail et al., 1994; Rao et 
al., 2006). Interestingly, the latter is a putative intermediate in TDM biosynthesis.  
Two disruptions isolated were in genes involved in metabolism, MSMEG1654 
(isocitrate dehydrogenase, icd) and MSMEG6756 (glycerol kinase, glpK). Isocitrate 
dehydrogenase is an enzyme of the tricarboxylic acid cycle (TCA cycle). It is highly 
likely that these metabolic pathways indirectly affect the biosynthetic pathways that 
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contribute to cell wall components. In addition to the above categories of genes, 
mutants having Tn insertions in an ABC transporter (MSMEG5102) and two genes 
with unknown function (MSMEG4256 and MSMEG3327) were identified. 
As for the M. marinum colony morphology mutants, we identified twenty genes 
with Tn insertions (Table 2.3). Amongst the five genes identified involved in cell wall 
and cell process, MMAR2327 (9D9) is a hypothetic protein with a homologue of a 
probable membrane glycosyltransferase, which is non-essential in M. tuberculosis 
(Lamichhane et al., 2003). MMAR2913 (10E9) is a glycine betaine transport integral 
membrane protein, in M. tuberculosis starvation model, the transcription of its 
homologue has been found to be up-regulated (Betts et al., 2002). MMAR5092 (12C3) 
is annotated as a lipoprotein, LpqF, its homologue in M. tuberculosis is identified as 
essential for growth but with an unknown function (Sassetti et al., 2003). MMAR2352 
(14D3) is a hypothetical protein with unknown function. MMAR325 (16D10) is a 
transmembrane protein, its homologue in M. tuberculosis has been identified to be 
required for survival in murine macrophages using Tn mutagenesis (Rengarajan et al., 
2005). 
Amongst the six genes identified involved in lipid metabolism, MMAR1767 
(1G2), membrane associated mycocerosic acid synthase (mas), MMAR1775 (6G3), 
phenolpthiocerol synthesis type-I polyketide synthase (ppsB) and MMAR1774 (16F2), 
phenolpthiocerol synthesis type-I polyketide synthase (ppsC), are all involved in 
biosynthesis of PDIMs, a cell wall lipid (Azad et al., 1997; Kruh et al., 2008; Mathur 
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& Kolattukudy, 1992). MMAR1180 (8D9-2) is annotated as a fatty acyl-AMP ligase 
FadD28_1, while its homologue in M. tuberculosis is polyketide synthase pks8 
(Rv1662), which has been reported together with pks17 (Rv1663) to be responsible for 
the production of monomethyl branched unsaturated fatty acids (Dubey et al., 2003); 
MMAR0978 (8G10, in promoter region) is methoxymycolic acid synthase 3, 
responsible for transferring a methyl group from S-adenosyl methionine (SAM) to 
form methoxymycolic acids, one of the three sub-groups of mycolic acids (Yuan & 
Barry, 1996); MMAR2341 (10G2) is annotated as fatty acyl-AMP ligase (fadD25), 
although the exact function is unknown, its homologue in M. tuberculosis has been 
suggested to be involved in lipid degradation (Betts et al., 2002).  
Amongst the two genes identified involved in intermediary metabolism and 
respiration, MMAR4806 (3E5) is a phytoene dehydrogenase (crtI) involved in 
carotene biosynthesis, which is a group of coloured terpenoids providing protective 
functions against photo-oxidative damage (Runyon, 1959). As shown in Fig. 2.2, 
mutant 3E5 lost the orange colour compared with the wild type strain, which is 
consistent with these observations. MMAR4214 (8D9-1) is serine protease (htrA or 
degP), whose homologue in M. tuberculosis has been predicted to be essential for 
pathogenicity (Ribeiro-Guimaraes & Pessolani, 2007). 
Among the remaining seven genes, one (MMAR5449, 6B11) is an Esat-6-like 
protein involved in virulence (Gao et al., 2004) and MMAR0992 (12B4) is a regulator 
gene with the remaining five conserved hypothetical proteins with unknown functions. 
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One mutant from each species was then selected for further studies as part of this 
thesis work.  
While the pbp cluster related mutants in M. smegmatis looked the most promising, 
these were not pursued any further due to the existence of already published literature 
on this topic (Dasgupta et al., 2006; Fernandez et al., 2006). Instead, the 3D9 (icd, 
MSMEG1654) mutant was chosen for further analysis for two reasons. Firstly, 
isocitrate dehydrogenase is one of the key enzymes in the central metabolism of the 
citric acid cycle (TCA cycle) which controls the isocitrate flux between the TCA cycle 
and glyoxylate bypass (LaPorte, 1993; Zheng & Jia, 2010). The first enzyme in 
glyoxylate shunt pathway in M. tuberculosis, isocitrate lyase (icl), has been reported 
to be involved in virulence (Munoz-Elias & McKinney, 2005). Secondly, in 
non-pathogenic mycobacteria, such as M. smegmatis, only one icd presents in their 
genomes, whilst M. tuberculosis and some other pathogenic mycobacteria have two 
copies. Phylogenetic analysis shows that in M. tuberculosis one is similar to 
prokaryotic icds, and the other to eukaryotic versions, indicating different function 
roles possibly related to virulence or intracellular survival. 
From the set of M. marinum mutants, the 8G10 (mmaA3, MMAR0978) mutant 
was also chosen for further study as it is the homologue of mmaA3 for M. tuberculosis 
and potentially involved in the biosynthesis of methoxymycolic acids. This provided 
an opportunity to study the role of methoxymycolic acids in virulence. 
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3.1 Introduction 
Bacteriophages have played an important role in the development of bacterial 
genetics and their utility as genetic tools for cloning and manipulation of genes is one 
of the most significant (Fitzgerald & Gasson, 1988; Kurzepa et al., 2009; Maloy & 
Gardner, 2007). Indeed in mycobacteria, phages have made an enormous contribution 
towards developing genetic tools for the manipulation of mycobacteria (Bardarov et 
al., 1997; Jacobs et al., 1989b; van Kessel et al., 2008). Attachment of a phage by 
binding to its receptor on the mycobacterial cell surface is important for initiating 
infection, and the study of phage-resistant mutants defective in phage adsorption is a 
useful approach to identifying these receptors. Phage receptors would be expected to 
be the outer components of the bacterial cell wall, and loss of this component would 
lead to phage resistance. Thus phage-resistant mutants would also be an extremely 
useful resource for the identification of biosynthetic pathways of mycobacterial cell 
wall components. Indeed, studies of interactions of bacteriophages with host cells 
have often led to the discovery of bacterial cell surface receptors and transporters that 
play important roles in microbial physiology. In E. coli, many membrane proteins and 
transporters were initially identified in phage resistant mutants (Heller, 1992), such as 
the maltose receptor (LamB) as the receptor for phage λ (Szmelcman & Hofnung, 
1975), the F-pilus for phage f1, the outer membrane ferrichrome (FhuA, formerly 
TonA) for phages T5, T1, and Φ80 (Braun, 1995) and vitamin B12 transporter (BtuB) 
for phage BF23 (Bradbeer et al., 1976). In other bacteria species, phage resistant 
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mutants have been used to identify cell wall components like polysaccharides and 
glycolipids, for instance the modified O-antigen lipopolysaccharides in Shigella 
(Verma et al., 1991), galactosamine-containing teichoic acids in Bacillus subtilis 
(Estrela et al., 1991) and N-acetylglugosamines of Listeria monocytogenes (Tran et al., 
1999).  
More than 250 mycobacteriophages have been identified since the 1950s (Hatfull, 
1994), some of them can infect a broad range of mycobacteria, as D29 which can 
infect fast-growing as well as slow-growing mycobacteria, and some of them have a 
limited range of hosts, as DS6A which can only infect the M. tuberculosis complex. 
Several mycobacteriophages have been well characterised and genetically modified 
for application in clinical diagnosis and research. For example, phage D29 was first 
isolated in 1954 (Froman et al., 1954) and its host includes M. smegmatis and M. 
tuberculosis. D29 is a lytic phage which kills the host cells when releasing progeny 
particles and forms clear plaques on the lawn of its host strain. It has been used as a 
typical model for understanding of mycobacteriophage infection process (David et al., 
1984a; David et al., 1984b; Jones & David, 1971). A D29 luciferase phage has been 
constructed for detecting mycobacteria (Ford et al., 1998). The genome of D29 is the 
second mycobacteriophage genome that has been sequenced after the temperate 
mycobacteriophage L5 (Ford et al., 1998). Comparative studies of both genomes 
revealed that D29 is a close relative to L5 but with a large deletion. These results can 
give us information of the biology, as well as the evolution of this group of 
mycobacteriophages. Phage TM4 is different from L5/D29. It was initially isolated 
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from a M. avium culture following mitomycin C treatment (Timme & Brennan, 1984). 
Although, TM4 can lyse M. smegmatis cells, the plaques it forms are different from 
those of lytic phages or temperate phages (Hatfull, 1994). TM4 has been used to 
construct the first mycobacterial phasmid which can grow as a plasmid in E. coli and 
as phage in mycobacteria (Jacobs et al., 1987), which has been widely used as a 
foreign DNA delivery system. Phage I3 is a temperate phage belonging to the 
Myoviridae family. It is also one of only two mycobacteriophages exhibiting 
generalised transduction and has been used as a genetic tool for transducing 
auxotrophic markers, as well as drug resistance markers (Lee et al., 2004; Raj & 
Ramakrishnan, 1970; Saroja & Gopinathan, 1973). However, I3 can only infect 
fast-growing mycobacteria but not slow-growing mycobacteria, such as M. bovis 
BCG and M. tuberculosis which restricts its uses as a genetic tool. A better 
understanding of the mechanism of its generalised transduction will be helpful for 
general phage biology, as well as developing new genetic tools. Recently, several new 
mycobacteriophages have been isolated, such as another generalised transducing 
phage BxZ1 (Lee et al., 2004) which forms clear plaques on M. smegmatis compared 
to the turbid plaques of phage I3.  
Despite a vast amount of work on mycobacteriophages, relatively little is known 
about mycobacteriophage receptors. Whilst, biochemical characterisation of cell 
extracts and phage adsorption experiments have shown that surface glycolipids of M. 
phlei are involved in the adsorption of mycobacteriophages D4 and D29 (Bisso et al., 
1976), resistance of M. smegamtis to phage D29 results in the emergence of new 
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pyruvylated, glycosylated acyltrehaloses (Besra et al., 1994), C-mycosides (PGL) and 
glycopeptidolipids (GPLs) are important for phage D4 adsorption (Dhariwal et al., 
1986), there have been no previous reports of a phage resistant mutant that is missing 
a cell wall component. There is only one report pertaining to a genetic basis for phage 
resistance which demonstrated that the overexpression of a multicopy phage resistant 
(mpr) gene in M. smegmatis led to resistance to phage D29 and L5 (Barsom & Hatfull, 
1996). Another study described the appearance of a new cell wall lipid species in a M. 
smegmatis strain spontaneously resistant to phage D29, rather than the disappearance 
of an existing cell wall component (Besra et al., 1994). 
As a case in study for demonstrating the utility of mycobacteriophage resistant 
mutants, the generalised transducing phage I3 was selected for screening an M. 
smegmatis transposon library for phage resistant mutants. This chapter describes the 
isolation and characterisation of phage I3 resistant M. smegmatis Tn-mutants, studies 
which were further extended to identify the minimal receptor for phage I3. Therefore, 
phage resistance was used as one of the screening strategies to study mycobacterial 
cell wall biosynthetic pathways. 
Additionally, a parallel line of studying examining mpr (multicopy phage 
resistant, MSMEG1236) was explored. Mpr was previously shown to confer an 
increased resistance to mycobacteriophage D29 and L5 when overexpressed in wild 
type M. smegmatis (Barsom & Hatfull, 1996). Phage D29 and L5 are two closely 
related mycobacteriophages that share similar mechanisms in infecting M. smegmatis 
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(Ford et al., 1998). Colony morphology changes were also observed in the 
recombinant strain and studies showed that the D29/L5 resistance may be caused by 
the inhibition of phage DNA injection after mpr overexpression. These combined 
results suggest that the function of the unknown mpr gene was possibly involved in 
modifying the cell wall. These early studies were followed by an analysis of the cell 
wall of a Δmpr mutant and strains overexpressing mpr using an inducible vector. 
3.2 Materials and Methods 
3.2.1 Bacterial strains, plasmids, phages and growth conditions 
Bacterial strains, mycobacteriophages and plasmids used in this study are listed in 
Table 3.1. M. smegmatis strains were grown at 37°C on Middlebrook 7H10 agar 
(Difco) and in Middlebrook 7H9 broth (Difco), supplemented with 0.2% glycerol and 
0.05% Tween 80. M. smegmatis was also grown on TSB (Difco) agar, in TSB broth 
supplemented with 0.05% Tween 80 and Sauton medium (for 1L, K2HPO4 0.5g, 
Mg2SO4·7H2O 0.5g, citric acid 2.0g, ferric ammonium citrate, 0.05g, glycerol 60ml, 
L-asparagine 4.0g, water to 1L) supplemented with 0.05% Tween 80. For phage 
infection experiments Tween 80 was omitted in all media. The antibiotics kanamycin 
and hygromycin B were added at concentrations of 25µg/ml and 100µg/ml for 
selection of M. smegmatis mc2155. Acetamide was added at a concentration of 0.2% 
for M. smegmatis transformants using the plasmid pSD26. E. coli was routinely 
grown in LB medium at 37°C. Mycobacteriophages were propagated on Middlebrook 
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7H9 with 0.2% glycerol and plaque forming units (pfu) of each phage and its 
multiplicity of infection (MOI) were estimated as described (Sarkis & Hatfull, 1998). 
Table 3.1 Plasmids, phages and bacterial strains used in this study 
Plasmids, phages and strains Discription Source or Reference
Plasmids   
pMV261 E.coli-mycobacterial shuttle plasmid, KanR (Stover et al., 1991) 
pMVgtf2 gtf2 cloned in pMV261, KanR (Miyamoto et al., 
2006) 
pSD26 E.coli-mycobacterial shuttle plasmid with 
acetamidase promoter, KanR 
(Parish & Brown, 
2008) 
pSD26MSMEG1236 mpr (MSMEG1236) cloned in pSD26, KanR This study 
Phages   
phAE185 Temperature sensitive derivative of 
mycobacteriophage TM4 containing the 
IS1096-derived transposon Tn5370 
(McAdam et al., 
2002) 
phAE181 Temperature sensitive derivative of 
mycobacteriophage TM4 containing the 
Himar1-derived transposon Tn5371 
(Kriakov et al., 2003)
I3 Generalized transducing mycobacteriophage (Raj & 
Ramakrishnan, 1970)
D29 Lytic mycobacteriophage (Froman et al., 1954)
BXZ1 Generalized transducing mycobacteriophage (Lee et al., 2004) 
Bacteria   
E .coli cc118λpir   
M. smegmatis mc2155 Parental (wile type strain) strain, Ept mutant (Snapper et al., 1990)
M. smegmatis Δgtf1 gtf1 disruptant of mc2155 (Miyamoto et al., 
2006) 
M. smegmatis Δgtf2 gtf2 disruptant of mc2155 (Miyamoto et al., 
2006) 
M. smegmatis Δgtf3 gtf3 disruptant of mc2155 (Miyamoto et al., 
2006) 
M. smegmatis Δgtf2/pMVgtf2 Δgtf2 complemented with a gtf2-containing 
plasmid 
(Miyamoto et al., 
2006) 
M. smegmatis Δmpr mpr disreptant of mc2155, HygR This study 
M. smegmatis mc2155/pSD26  Wild type strain with pSD26, KanR This study 
M. smegmatis 
mc2155/pSD26MSMEG1236 
Wile type strain with mpr overexpressed, KanR This study 
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3.2.2 Isolation of mycobacteriophage resistant mutants 
Individual M. smegmatis clones from the Tn-mutant library were spotted with 
96-spike replicator onto plates with TSB agar, containing 1010pfu per plate of 
mycobacteriophage I3. All phage resistant candidates were purified for single colonies 
and retested for resistance to phage I3 by a phage sensitivity test. 
3.2.3 Phage sensitivity test 
M. smegmatis mc2155 and I3 phage mutants were grown to an OD600 of 1 and 
100μl of fresh culture of each strain was mixed with molten 7H9 soft agar (0.6%) and 
overlaid onto a basal 7H9 agar plate. A high titre phage lysate was ten-fold serially 
diluted to about 100pfu/ml. On each plate, 10μl of each phage lysate dilution was 
spotted on the plates overlaid with M. smegmatis cells. Plates were incubated at 37°C 
for 1-2 days to visualise plaques. D29 and BxZ1 phages were used as controls in this 
study. 
3.2.4 Biochemical characterisation of GPLs 
Polar lipids were extracted as described in Chapter 7 and then subjected to alkali 
treatment to remove acetyl/acyl substituents as described previously (Burguiere et al., 
2005a). The dried polar lipids were resuspended in 4 ml of CHCl3/CH3OH/0.8M NaCl 
(10:10:3, v/v/v) and incubated at 55°C for 15 min. The mixture was allowed to cool at 
room temperature. After CHCl3 (1.75ml) and H2O (0.25ml) were added, the mixture 
was mixed on rotary for 10 min and centrifuged. The lower organic layer was washed 
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twice with 2ml of CHCl3/CH3OH/H2O (3:47:48, v/v/v). The lower organic layer, 
containing base stable polar lipid, was dried and resuspended in 200µl of 
CHCl3/CH3OH (2:1, v/v); 5µl was dried in a scintillation vial and then mixed with 
5ml of scintillation fluid and had its radioactivity measured. Equivalent amounts 
(10,000 cpm) of each sample were spotted on TLC plates (5735 silica gel 60F524; 
Merck) for further one dimensional (1D-) TLC in CHCl3/CH3OH/H2O (90:10:1, v/v/v) 
as described (Burguiere et al., 2005a). TLC results were visualised by exposing to 
Kodak X-Omat film overnight. 
3.2.5 Phage adsorption assay 
Wild type and mutant strains of M. smegmatis were grown to OD600 of 1. Cells 
were washed with MP buffer and were infected with I3 phage with MOI of 1 for 1 
hour. After infection, cells were treated with DNaseI to digest extracellular phage 
DNA and washed four times with PBS with 0.1% Tween 80. Subsequently, total 
DNA was extracted from cells. The presence of injected I3 phage DNA in M. 
smegmatis cells was detected by PCR using primer specific for I3 phage structural 
protein (gi|15097|emb|X68296.1, primer forward 5’GTACAACCCGCCAACCCAC 
3’ and primer reverse 5’CAGGCGGACGAGATAGGTG 3’) performed with 10μg of 
total DNA extracted from cells as template. 
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3.2.6 Construction of phasmid for knocking out mpr in M. smegmatis 
Left and right flank sequences of mpr (MSMEG1236) were amplified by PCR 
using primers listed in Table 3.2. PCR products were purified (QIAquick PCR 
Purification Kit, QIAGEN) and digested with Van91I (NEB). Digested left and right 
flank fragments were ligated with P0004s Van91I-digested fragments. The ligation 
mixture was then transformed into E. coli Top10 and selected onto LB agar with 
hygromycin at 37°C overnight. Plasmids recovered from E. coli Top10 were digested 
by PacI and ligated with PacI-digested phAE159 DNA after confirmation by 
sequencing. Ligated knock-out plasmid and phAE159 DNA were packaged into λ 
phage heads and transduced into E. coli HB101 and selected on LB agar with 
hygromycin at 37°C overnight. 
Table 3.2 Primers used for knocking out mpr in M. smegmatis 
Name Sequences (5'-›3') Product Size
MSMEG1236_LL TTTTTTTTCCATAAATTGGCATCCCGCCCTCCCGTCG *
MSMEG1236_LR TTTTTTTTCCATTTCTTGGCCGGGGTGTTGATTGTTGC 
left side flank 
sequence of mpr  
961 
bp 
MSMEG1236_RL TTTTTTTTCCATAGATTGGCAGCCCGTCGAATCAGAAG
MSMEG1236_RR TTTTTTTTCCATCTTTTGGCGGGCTGCTCGAGTCGC 
right side flank 
sequence of mpr  
1051 
bp 
*Sequence underlined represents Van91I enzyme site. 
3.2.7 Preparation of recombinant deletion of mpr in M. smegmatis 
Cosmids recovered from E. coli HB101 were then transformed into M. smegmatis 
by electroporation after being confirmed and M. smegmatis cells were recovered in 
TSB at 30°C for 3-4 hours. Cells were then harvested and mixed with 200μl of fresh 
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late-log phase M. smegmatis culture and 4 ml of molten 7H9 soft agar. Cells were 
overlaid onto basal 7H9 agar plates and incubated at 30°C for 2-3 days to form 
plaques. Phage plaques were patched for making high titre phage lysate for future 
transductions. 
3.2.8 Phage transduction 
M. smegmatis cultures were grown in 50ml of TSB (0.05% Tween 80) to an 
OD
600nm 
of 0.8. Cells were harvested by centrifugation at room temperature and 
washed with 50 ml MP buffer. Cells were resuspended in 5 ml MP buffer and mixed 
with high titre phage lysate (10
10 to 10
11
pfu/ml) at an MOI of 10, while 0.5ml cells 
were mixed with 0.5ml MP buffer as control. After overnight incubation at 37°C, 
cells were harvested and resuspended in 25ml TSB with 0.05% Tween 80. Cells were 
recovered at 37°C for 24 hours before being plated onto TSB agar plates with 
hygromycin B. Plates were incubated at 37°C for 1-2 weeks. Colonies were 
inoculated at 10ml of TSB (0.05% Tween 80) with hygromycin B for further study. 
3.2.9 Southern Blot 
 SacI digested genomic DNA from M. smegmatis wild type and Δmpr mutant 
stains were applied to gel electrophoresis to separate DNA fragments by size. In the 
mutant, the mpr gene was replaced with a hygR gene. There were four SacI cutting 
sites in hygR while none in mpr. PCR products of left and right flank sequences of mpr 
(MSMEG1236) were used as probes. Thus, after SacI digestion, there would be only 
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one fragment (~4.5kb) from wild type genomic DNA that can be detected, while two 
(2.2kb and 1.8kb) from genuine Δmpr mutants. The agarose gel was then applied to 
depurination (0.2M HCl, 15 min), denaturation (1.5M NaCl, 0.5M NaOH, 15 min) 
and nuetralisation (0.5M Tris-HCl pH7.2, 1M NaCl, 15 min). Then DNA was 
transferred onto nylon membrane (positively charged) by capillary transfer with 
20×SSC (3M NaCl, 0.3M sodium citrate, pH7.0). DNA on membrane was fixed by 
UV-crosslinking. The membrane was rinsed with distilled water and air-dried.  
DIG High Prime DNA Labeling and Detection Start Kit II (Roche) was used for 
probe labeling, hybridisation and detection. The procedure was performed as 
described in the instruction manual. Briefly, digoxigenin (DIG), a steroid hapten, was 
used to label DNA probes according to the random primed labeling technique. The 
hybridized probes were immunodetected with anti-digoxigenin-AP, Fab fragments 
and were then visualized with the chemiluminescence. 
3.3 Results 
3.3.1 Isolation of phageI3-resistant M. smegmatis Tn mutants 
Based on the hypothesis that changes in cell wall components can lead to changes 
in susceptibility of mycobacteriophage infection, M. smegmatis Tn-mutants were 
spotted onto phage I3 seeded agar plates to select phage-resistant mutants. Two 
Tn-mutant libraries were used for screening, one generated with HimarI-derived 
Tn5371 and other with IS1096-derived Tn5370 (Cirillo et al., 1991; McAdam et al., 
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2002). Altogether four I3-resistant mutants were identified, three from the Tn5371 
library and one from the Tn5370 library. The I3-resistance of the mutants was 
confirmed twice after single colony purification. As shown in Fig. 3.1, compared with 
the wild type strain the mutants were resistant to I3 phage. 
3.3.2 Phage I3 fails to inject DNA into I3-resistant M. smegmatis Tn-mutants 
In order to differentiate whether the resistance was caused by failure to initiate 
infection or due to a later replication stage specific defect, an assay was performed to 
test if phage DNA could be detected in the cells following phage adsorption. The 
results showed that intracellular phage I3 genomic DNA could be detected by PCR 
from M. smegmatis mc2155 cells pre-adsorbed with phage I3, but not from phage 
resistant mutants indicating that the phage failed to inject DNA into the phage 
Fig. 3.1 Sensitivity of M. smegmatis GPL-associated glycosyl 
transferase mutants to phages I3, D29 or BxZ1. Ten fold dilutions of 
phages (10μl, 10-2 to 10-6) spotted from left to right on soft agar overlays 
on 7H9-agar plates containing either wild type strain or I3-resistant 
mutants 
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resistant mutants (Fig. 3.2, lane 4). 
 
3.3.3 Identification of disrupted genes in phage I3-resistant M. smegmatis 
Tn-mutant  
Using the Tn-insertion rescue method described in chapter 2, genes disrupted in 
I3-resistant M. smegmatis Tn-mutants were identified. As shown in Table 3.3, all four 
phage I3-resistant mutants had a Tn insertion in genes associated with a cluster 
involved in the biosynthesis of GPLs, the outermost ‘free’ lipids found in M. 
smegmatis. Glycosyl transferase (gtf2, MSMEG0392) is responsible of transferring 
O-methyl-rhamnose onto the fatty acyl-tetrapeptide core (FATP) core, the inactivation 
of GTF2 leads to the accumulation of fatty acyl-tetrapeptide core (FATP) core with 
Fig. 3.2 PCR amplification of part (461 bp) of a 
phage I3 gene encoding a 17kD structural 
protein. Lane 1, DNA size markers; lane 2, PCR 
positive control using phage I3 DNA as template; 
lanes 3, 4 and 5, PCR reaction using total DNA 
extracted from M. smegmatis wild type strain, 
I3R-1 and gtf2 respectively, each of which was 
pre-adsorbed with phage I3. 
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6-deoxy-talose-FATP (Miyamoto et al., 2006). MSMEG0400 is a hypothetical protein 
with a conserved MbtH-like domain, although its function is not clear, it has been 
reported that this MbtH-like protein is found in almost all non-ribosomal peptide 
synthetase (NRPS) biosynthetic gene clusters (Stegmann et al., 2006). MSMEG0400 
(mps1) and MSMEG0401 (mps2) are responsible of synthesis of the dipeptide and the 
amino acid alcohol in FATP core, respectively (Ripoll et al., 2007).  
Table 3.3 Genes disrupted in phage I3-resistant M. smegmatis Tn-mutants 
Mutant Disrupted gene Function 
I3R-1 MSMEG0392 Glycosyl transferase (gtf2) 
I3R-2 MSMEG0399 MbtH-like protein 
I3R-3 MSMEG0400 Non-ribosomal peptide synthase (mps1) 
I3R-4 MSMEG0401 Non-ribosomal peptide synthase (mps2) 
3.3.4 Phage I3-resistant M. smegmatis mutant strains are defective in GPL 
biosynthesis 
As mentioned above, all I3-resistant Tn-mutants had insertions in genes 
previously identified to play a role in GPL biosynthesis. GPLs are a group of complex 
lipids abundant in the outer envelope of M. smegmatis and other mycobacteria 
(Billman-Jacobe, 2004; Schorey & Sweet, 2008). M. smegmatis produces six 
sub-classes of GPLs each of which has a common fatty acyl-tetrapeptide (FATP) core 
consisting of a tetrapeptide amino alcohol (D-Phe-D-allo-Thr-D-Ala-L-alaninol) 
linked to a C26–C34 fatty acyl chain via an amide bond (Miyamoto et al., 2006) (Fig. 
3.3).  
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GPL-1, 2, 3 and 4 all contain a rhamnose (with varying levels of O-methylation) 
and 6-deoxy-talose as sugar residues (Miyamoto et al., 2006). GPL-5 and GPL-6 
contain an additional rhamnose or O-methyl rhamnose attached to the original 
rhamnose residue. Given the association of the Tn insertion in the phage I3-resistant 
mutants with genes involved in GPL biosynthesis, it was likely that the mutants were 
affected in GPL biosynthesis. However, to have a comprehensive picture of lipid 
biosynthesis in the mutants, a complete analysis of polar and non-polar lipids from the 
I3-resistant mutants was performed using 2D-TLC (Dobson et al., 1985). The analysis 
Fig. 3.3 Simplified representations of the structures of GPLs found in M. 
smegmatis. (a) GPLs in wild type strain, (b, c) biosynthetic intermediates that 
accumulate in ∆gtf1, (d) biosynthetic intermediates that accumulate in ∆gtf2. Rha, 
rhamnose; di-Ac 6-d-Tal, di-acetylated 6-deoxy talose; Me; methyl; Variations in 
the fatty acyl chain (R) are not shown. 
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revealed, not surprisingly, a loss of GPLs in all the mutants (Fig. 3.4 System D [polar 
lipids]). None of the other cell-wall associated lipids were altered in any of the 
mutants (Fig. 3.4 System A-D [non-polar lipids] and System E [polar lipids]) except 
spots in System C and System D of non polar lipid for I3-1 mutant, which need to be 
further identified (Fig. 3.4, labelled with circle) 
Additionally, lipid extracts treated with alkali to detect deacetylated GPLs was 
performed. TLC analysis used for separation of deacetylated sub-classes 1-4 of GPLs 
showed that these sub-classes were absent in the phage I3-resistant mutants (Fig. 3.5). 
These results suggested a role for GPLs in binding of phage I3 to the M. smegmatis 
cell surface. 
Fig. 3.4 Lipid profiles of I3-resistant M. smegmatis Tn-mutants (TSB). Ac2PIM2 and AcPIM2 di- 
and monoacyl phosphatidylinositol dimannosides, Ac2PIM6 and AcPIM6 di- and monoacyl 
phosphatidylinositol hexamannosides, GPLs glycopeptidolipids, PI phosphatidyl inositol, PL 
phospholipid, TDM trehalose dimycolates, TMM, trehalose monomycolates; TAG-triacylglycerol  
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3.3.5 Loss of GPLs correlates specifically to phage I3 resistance 
GPLs are one of the outermost lipids of the mycobacterial envelope. Given this 
location, it is likely that phage resistance was not due to the loss of a phage I3 
receptor, but due to a non-specific effect affecting a pre-adsorption stage of 
mycobacteriophages. If this was true, the isolated mutants would be resistant to a 
wider range of mycobacteriophages. To test if this was the case, sensitivity of the 
I3-resistant mutants to two other lytic mycobacteriophages, D29 and BxZ1, was 
examined. Both phages were able to form plaques on lawns of wild type and phage 
I3-resistant mutants indicating that GPL-deficiency did not affect the normal course 
of infection for these phages (Fig. 3.1). Therefore, GPL deficiency specifically caused 
Fig. 3.5 TLC analysis of deacetylated GPLs of I3-resistant M. smegmatis 
Tn-mutants. Deacetylated polar lipids were separated using the solvent 
system CHCl3:CH3OH:H2O (90:10:1, v/v) to visualise GPLs 1, 2, 3 and 4 
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resistance to phage I3 and, thus, this class of lipids were likely the receptors for phage 
I3. 
Given that one of the Tn insertions was in a glycosyl transferase, gtf2, we also 
tested an independently generated targeted knockout mutant of gtf2 (Miyamoto et al., 
2006) for sensitivity to phage I3. The strain Δgtf2 was also resistant to phage I3, and 
the I3 sensitivity was restored in the complemented strain, Δgtf2/pMV261gtf2 (Fig. 
3.6). Also similar to the Tn-mutant, Δgtf2 was sensitive to BxZ1 and D29. 
 
3.3.6 Minimal structural requirements for the phage I3 receptor 
As mentioned above, there are sub-classes of GPLs (Fig. 3.3), with deficiencies 
in levels of glycosylation. In order to further elaborate on the minimal structure 
required for phage adsorption, a set of previously described M. smegmatis mutants 
that produced truncated GPL intermediates was examined. The sequence of assembly 
Fig. 3.6 Sensitivity of M. smegmatis GPL-associated glycosyl transferase mutants 
to phages I3, D29 or BxZ1. Ten fold dilutions of phages (10μl, 10-2 to 10-5) spotted 
from left to right on soft agar overlays on 7H9-agar plates containing either wild type 
or glycosyl transferase mutants
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of sugar residues in GPLs was identified by Miyamoto et al. by specifically deleting 
gtf1, gtf2, gtf3 and gtf4, the four genes encoding glycosyltransferases in M. smegmatis 
mc2155 (Miyamoto et al., 2006). Gtf1 was involved in the transfer of deoxytalose to 
the FATP core and consequently the Δgtf1 mutant lacked all classes of GPLs and 
instead accumulated the intermediates FATP-3,4-di-O-methyl rhamnose and 
FATP-2,3,4-tri-O-methyl rhamnose (FATP-di-O-Me-Rha and FATP-tri-O-Me-Rha; 
Fig. 3.3 b, c). Similarly, Gtf2 was involved, independently, in the transfer of 
rhamnose to the FATP core and the Δgtf2 mutant, which also lacked all classes of 
GPLs, accumulated FATP-6-deoxytalose (Fig. 3.3 d). On the other hand, Gtf3 was 
involved in the transfer of the second rhamnose residue and subsequently only GPL-5 
and GPL-6 were missing in the Δgtf3 mutant. There were no differences in lipid 
profiles of the Δgtf4 mutant compared with wild type strain. The accumulation of 
different intermediates of GPL biosynthesis in these mutants allowed these strains to 
identify the specific structural components of GPL that defined the receptor of phage 
I3. The Δgtf1, Δgtf3 and Δgtf4 mutants were all sensitive to infection by phage I3, 
although the plaquing efficiency of phage I3 on a lawn of the Δgtf1 mutant was 
diminished (Fig. 3.6). On the other hand, the Δgtf2 mutant was found to be 
phage-resistant, and complementation of the Δgtf2 mutant with plasmid encoded gtf2 
restored phage sensitivity (Fig. 3.6). This was consistent with the phage resistance 
phenotype of the Tn-mutant I3R-1 which had a Tn insertion in gtf2. Also, resistance of 
the Δgtf2 mutant to phage I3 correlated with the inability to detect intracellular phage 
DNA by PCR following adsorption with phage (Fig. 3.2). Also, like the I3-resistant 
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Tn-mutants, the Δgtf2 mutant retained sensitivity to phages D29 and BxZ1 (Fig. 3.6). 
These results indicated that addition of the first rhamnose residue to the FATP was 
critical for phage I3 infection and thus the FATP containing a single di or 
tri-O-methylated rhamnose was sufficient to allow binding of phage I3. However, the 
reduced plaquing of phage I3 on lawns of the Δgtf1 mutant (which accumulates 
FATP-di-O-Me-Rha and FATP-tri-O-Me-Rha) indicated that while talose was not 
required for phage binding, it likely affects binding efficiency. 
3.3.7 Deletion of mpr in M. smegmatis and phage sensitivity of Δmpr 
To identify the function of mpr and its role in phage D29 and L5 binding and 
consequently to understand the resulting changes in the cell wall, two approaches 
were undertaken. Firstly, a M. smegmatis Δmpr mutant, and secondly, overexpression 
of mpr in M. smegmatis using an inducible acetamide promoter. In both approaches, 
cell wall lipids would be analysed and compared to a control strain (the wild type 
strain and the wild type strain with an empty vector control). 
According to the results from the previous study (Barsom & Hatfull, 1996) using 
overexpression of mpr in M. smegmatis, which suggested that mycobacteriophage 
resistance could be involved in a cell wall component biosynthetic process or other 
related function. The Δmpr mutant was confirmed by Southern blot using DIG-labled 
(digoxigenin-dUTP, alkali-labile, Roche) PCR fragment of left and right side flanks. 
As shown in Fig. 3.7, one band (~4.5kb) was detected in SacI digested genomic DNA 
from the wild type strain and two bands (2.2kb and 1.8kb) from both Δmpr mutants 
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indicating that both mutants were genuine. The M. smegmatis Δmpr1 was used for 
further studies. Phage sensitivity was compared between the wild type and M. 
smegmatis Δmpr mutant strain. As shown in Fig 3.8, there was no distinctive 
difference in sensitivity to phage D29, I3 and BxZ1, between the wild type and the 
mutant strain.  
 
Fig. 3.7 Confirmation of Δmpr mutants by 
Southern blot. SacI digested genomic DNA 
from wild type strain (lane 1), Δmpr(1)(lane 
2) andΔmpr(2)(lane 3) digested with SacI 
and probed with the same flank sequences 
used for constructing knock-out phasmid. 
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Since the phage resistant phenotype was observed under the condition of 
overexpression of mpr, deletion of mpr may not have the same effect. Although, it 
was still possible that the cell wall structure could be changed if mpr was involved in 
any function related to cell wall composition, lipid profiles, as well as fatty acids and 
mycolic acids of wild type strain and mutant were analysed by [14C]-acetate labeling. 
The results of TLC analysis showed no distinct difference between the wild type and 
the M. smegmatis Δmpr mutant strain (Fig. 3.9), when cultured in either TSB with 
Tween 80 or Sauton medium with Tween 80 respectively. However, there was a 
difference in System C of non polar lipid, when comparing the same strain in different 
media (Fig. 3.9 labelled with circle). When cultured in Sauton medium with Tween 80, 
both M. smegmatis wild type and Δmpr mutant gave one spot in System C, of non 
polar lipid, running behind the normal fatty acid spot. Because this pattern was 
consistent between wild type and mutant strain, it might be caused by the different 
medium used for culturing. However, these spots need to be further identified. 
 
Fig. 3.8 Sensitivity of M. smegmatis Δmpr mutant to phages I3, D29 
or BxZ1. Ten-fold dilutions of phages (10μl, 10-2 to 10-7) spotted from 
left to right on soft agar overlays on 7H9-agar plates containing either 
wild type or Δmpr mutant. 
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Fig. 3.9 Lipids profiles and FAMEs/MAMEs analysis of M. smegmatis Δmpr mutant. A. 
2D-TLC analysis of nonpolar and polar lipids of M. smegmatis cultured in TSB with Tween 80 or 
Sauton with Tween 80. B. 1D-TLC analysis of FAMEs/MAMEs of M. smegmatis cultured in 
TSB with Tween 80 or Sauton with Tween 80. 1-M. smegmatis wild type, 2- M. smegmatis Δ
mpr; a-whole FAMEs/MAMEs, b-cell wall bound FAMEs/MAMEs. Ac2PIM2 and AcPIM2 di- 
and monoacyl phosphatidylinositol dimannosides, Ac2PIM6 and AcPIM6 di- and monoacyl 
phosphatidylinositol hexamannosides, GPLs glycopeptidolipids, PI phosphatidyl inositol, PL 
phospholipid, TDM trehalose dimycolates, TMM trehalose monomycolates, 
TAG-triacylglycerol, FAME fatty acid methyl ester, MAME mycolic acid methyl ester. 
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3.3.8 The effect on phage sensitivity and cell wall components of mpr 
overexpressed in M. smegmatis 
The phage resistance phenotype was observed in M. smegmatis when mpr was 
overexpressed in a previous study (Barsom & Hatfull, 1996). Thus, the acetamide 
inducible pSD26 vector was used to construct pSD26MSMEG1236 to increase the 
expression of Mpr in the wild type strain and then test for phage sensitivity. As shown 
in Fig. 3.10, the phage sensitivity to D29/I3/BxZ1 of the Mpr-overexpressed strain 
was similar compared to the wild type strain.  
The cell wall components were further analysed from cultures grown in 7H9 
broth without Tween 80. There were bands in System C of non polar lipid of both  
pSD26 and mpr overexpressed strain, compared to wild type strain (Fig. 3.11 labelled 
in circle). These bands were at the similar position to fatty acids and need to be 
further identified. However, because the pattern was consistent between wild 
type/pSD26 and mpr overexpressed strain, this change may be caused by the pSD26 
vector or the acetamide used for protein overexpression rather than the overexpression 
Fig. 3.10 Sensitivity of M. smegmatis mpr overexpressed strain to phages I3, D29 or 
BxZ1 Ten fold dilutions of phages (10μl, 10-2 to 10-7) spotted from left to right on soft 
agar overlays on 7H9-agar plates containing either wild type or Δmpr mutant 
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of mpr. No other differences were found either in the lipid profiles, fatty acids or 
mycolic acids (Fig. 3.11). 
 
3.4 Discussion 
Most mycobacteriophages belong to the family Myoviridae or Sophoviridae, 
encompassing phages with either contractile or long tails (Ackermann, 2001). It is 
Fig. 3.11 Lipid profiles and FAMEs/MAMEs analysis of M. smegmatis mpr overexpressed strain. 
A. 2D-TLC analysis of non-polar and polar lipids of M. smegmatis cultured in 7H9 broth without 
Tween 80. B. 1D-TLC analysis of FAMEs/MAMEs M. smegmatis cultured in 7H9 broth without 
Tween 80. 1-M. smegmatis wild type, 2- M. smegmatis/pSD26, 3- M. smegmatis/pSD26MSMEG1236; 
a-whole FAMEs/MAMEs; b-cell wall bound FAMEs/MAMEs Ac2PIM2 and AcPIM2 di- and monoacyl 
phosphatidylinositol dimannosides, Ac2PIM6 and AcPIM6 di- and monoacyl phosphatidylinositol 
hexamannosides, GPLs glycopeptidolipids, PI phosphatidyl inositol, PL phospholipid, TDM trehalose 
dimycolates, TMM trehalose monomycolates, TAG triacylglycerol, FAME fatty acid methyl ester, 
MAME mycolic acid methyl ester. 
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speculated that this tail morphology may be particularly relevant to 
mycobacteriopages, helping the injection of phage DNA through an exceptionally 
thick, carbohydrate and lipid-rich cell wall (Aspinall et al., 1995). Interestingly, the 
sequencing of a number of mycobacteriophage genomes has revealed that the 
phage-tail associated tape measure proteins from mycobacteriophages contain a 
number of domains, some of which are similar to those involved in host-encoded PG 
degrading enzymes (Piuri & Hatfull, 2006), suggesting that these additional domains 
possibly aid viral DNA injection via localised cell wall degradation and thus play a an 
important role in initialling infection. However, these early events in phage infection 
are dependent on, and pre-ceded by, the specific binding of phage to its cell surface 
receptor on the bacterial envelope. In this study we have used Tn-mutants to identify 
GPLs as the M. smegmatis cell surface receptor for phage I3, which belongs to the 
family Myoviridae. Phage resistance was not due to a non-specific effect caused by 
alterations in the cell wall, since the phage I3 resistant mutants retained sensitivity to 
other mycobacteriophages, such as D29 and BxZ1. This work highlights the utility of 
phage resistance screens to identify genes involved in the biosynthesis/transport of 
cell envelope components. Whilst in this case, sequencing of Tn insertion sites in the 
phage I3-resistant mutants revealed insertions in a well studied gene cluster involved 
in GPLs biosynthesis, the availability of numerous mycobacteriophages would allow 
screening for mutants defective in their corresponding phage receptors viz a 
mycobacterial cell wall components. Indeed, this work showed that the phages D29 
and BxZ1 have receptor(s) are distinct from for phage I3, as the I3-resistant mutants 
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retained sensitivity to these phages. More than 250 mycobacteriophages have been 
isolated to date (Barksdale & Kim, 1977; Hatfull, 1994) and only a few have been 
studied in detail (Hatfull, 2005). Mycobacteriophages show diversity in genome 
sequences, morphology and in host range (Pedulla et al., 2003) and it is quite likely 
that this diversity is also reflected in the nature of their corresponding receptors in the 
cell wall of mycobacteria. Besides, studies on phage receptors may also aid the further 
development of phage typing as a diagnostic tool for the identification of strains of 
pathogenic mycobacteria that produce variants of cell surface components. 
Further analysis using defined M. smegmatis mutants that accumulated GPL 
intermediates showed that a FATP with 3,4-di or 2,3,4-trimethylated rhamnose 
(FATP-di-O-Me-Rha and FATP-tri-O-Me-Rha) was the minimal structural 
requirement for phage I3 binding. However, the lower phage adsorption efficiencies 
observed with the Δgtf1 mutant (which accumulates FATP-di-O-Me-Rha and 
FATP-tri-O-Me-Rha) indicated that while the 6-d-Tal residue was not essential for 
phage infection to occur, the presence of this sugar had an effect on phage binding 
efficiency. On the other hand, the second rhamnose residue seemed non-essential for 
phage binding as the Δgtf3 mutant (which lacks the second rhamnose-containing 
GPL-5 and GPL-6) did not show any differences in sensitivity to phage I3 as 
compared to the wild type strain. 
Interestingly, M. avium, which also produces GPLs seems naturally resistant to 
phage I3 (Lee et al., 2004). This may be either because a rough variant of M. avium 
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(that does not produce GPLs) was used to assay infectivity, or because the 
glycosylation of the deoxytalose residue in M. avium GPLs may have a ‘masking’ 
effect that prevents the recognition of methylated rhamnose by phage I3. 
Previous studies have shown that the elevated expression of mpr (MSMEG1236) 
gene in M. smegmatis leads to the resistance of the recombinant strain to both 
mycobacteriophage D29 and L5 (Barsom & Hatfull, 1996). Although the exact 
function of mpr is unknown, the change of colony morphology, as well as the 
inhibition of phage DNA infection indicates that this gene is involved in cell wall 
component biosynthesis or modifying a structure but not as the receptor for phage 
infection considering the resistance appears when it is overexpressed. Initially, a M. 
smegmatis Δmpr mutant was used to study whether there would be any change in 
phage sensitivity or cell wall composition, lipid profile, fatty acids and mycolic acids. 
No difference was observed in both scenarios. Given the condition of elevated 
expression of mpr when the phage resistant phenotype is observed in previous study, 
an inducible expression vector pSD26 was used to elevate expression levels of mpr in 
M. smegmatis for further phage sensitivity and cell wall composition studies. Unlike 
the previous study, phage resistance in the ovexpression strain to phage D29 was not 
observed. In addition, no distinct difference was observed in cell wall composition. 
According to the previous study, one extra copy of mpr is not sufficient to confer a 
phage-resistant phenotype (Barsom & Hatfull, 1996). Thus, one possible reason for 
failing to repeat the phage resistant phenomenon, in this study, might be the different 
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expression systems used in both studies which could affect the level of expression and 
further affect the phenotype. 
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4.1 Introduction 
This chapter describes the characterisation of a M. marinum Tn-mutant 8G10 
isolated from the colony morphology screen described in Chapter 2. The mutant 
contains a Tn insertion in the promoter region of MMAR0978, a gene encoding a 
O-methyl transferase. The region surrounding MMAR0978 showed synteny with the 
M. tuberculosis cluster encoding genes involved in the biosynthesis of oxygenated 
mycolic acids. Mycolic acids are major components of the mycobacterial cell 
envelope. These unique long chain α-alkyl, β-hydroxy fatty acids are found either 
covalently linked to the cell wall mAGP complex or in the outer layers of the cell 
envelope as free glycolipids. Structural diversity in sub-classes of mycolic acids 
include variations in mero-chain length and mero-chain modifications (e.g. 
unsaturations, cyclopropanations, methylation) (Yuan & Barry, 1996). M. 
tuberculosis and M. bovis synthesise three sub-classes of mycolates: α-, keto and 
methoxy. The α--mycolic acids contain two cis-cyclopropane rings in the mero-chain, 
whilst the oxygenated mycolates contain either a proximal cis or trans cyclopropane 
ring (Yuan & Barry, 1996). Additionally, keto and methoxymycolates contain a distal 
keto and methoxy group, respectively (Yuan & Barry, 1996). Modifications of the 
mero-chain play an important role in virulence (Dao et al., 2008; Dubnau et al., 2000; 
Glickman et al., 2000; Rao et al., 2006; Ueda et al., 2001) and also affect 
susceptibility to drugs (Barkan et al., 2009; Glickman et al., 2000). 
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In M. tuberculosis, mmaA3 encodes an O-methyltransferase responsible for the 
biosynthesis of methoxymycolic acids. Functional evidence of this came from mmaA3 
overexpression studies in M. tuberculosis and M. bovis BCG, where overproduction 
of M. tuberculosis MmaA3 resulted in a complete replacement of ketomycolates by 
methoxymycolates, and from in vitro assays using purified MmaA3 (Yuan et al., 
1998). Additionally, the failure of several strains of M. bovis BCG to produce 
methoxymycolic acids correlated with a mutation in mmaA3. Furthermore, 
methoxymycolate production could be restored in these M. bovis BCG strains 
following introduction of a wild type copy of M. bovis BCG mmaA3 (Belley et al., 
2004). While the role of oxygenated mycolic acids (as a group) in M. tuberculosis 
virulence has been studied using a mutant strain that is unable to synthesise both keto 
and methoxymycolates (Dubnau et al., 2000), the specific effects of loss of only 
methoxymycolates in pathogenic strains remains to be studied. Whilst, M. marinum 
produces the same sub-classes of mycolic acids as M. tuberculosis, unlike in the latter, 
oxygenated mycolates from M. marinum are not cyclopropanated and contain 
mero-chain double bonds (Daffe et al., 1991a). 
M. marinum is a pathogen of fish and amphibians and shares many virulence 
traits of M. tuberculosis infection, such as the ability to survive and replicate within 
macrophages, formation of granulomatous lesions and reactivation (Pozos & 
Ramakrishnan, 2004). M. marinum has thus been used extensively as a surrogate for 
studying mycobacterial pathogenesis using the zebrafish model of infection (Stamm 
& Brown, 2004). The virulence of M. marinum can be assessed in a zebrafish model, 
Chapter 4 Impact of Mycolic Acid Modification on the Virulence of Mycobacterium marinum 
 89
that infected embryos have been used to observe macrophage aggregation and 
granuloma formation, as well as infected adult fish have been used to study both 
innate and adaptive immune responses and granuloma formation (Pozos & 
Ramakrishnan, 2004). The studies described in this chapter include the biochemical 
characterisation of the 8G10 Tn-mutant and also an assessment of the effects of the 
mutant on virulence using a zebrafish infection model. 
4.2 Materials and Methods 
4.2.1 Bacterial strains, plasmids and culture conditions 
The bacterial strains and plasmids used in this study are listed in Table 4.1. 
Mycobacterial strains were grown in 7H9 broth with 0.05% Tween 80 and on 7H10 
agar at 30°C. E. coli was grown in LB broth at 37°C. The antibiotics hygromycin, 
kannamycin and apramycin were added either at concentrations of 75μg/ml, 25μg/ml 
and 30μg/ml, respectively for M. marinum, or 150μg/ml, 50μg/ml and 30μg/ml for E. 
coli where required.  
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Table 4.1 Plasmids and bacterial strains used in this study 
Plasmids, phages and strains Discription Source or 
Reference 
Plasmid   
pMV261 E. coli-mycobacterial shuttle plasmid, KanR (Stover et al., 
1991) 
pMV261MMAR0978 M. marinum MMAR0978 was cloned in to pMV261, 
KanR 
This study 
pMV261Rv0643c M. tuberculosis Rv0643c was cloned in to pMV261, KanR This study 
pMSP12-dsRed-Apr E. coli-mycobacterial shuttle plasmid, containing dsRed 
and AprR 
This study 
Bacteria   
E. coli TOP10   
M. marinum 1218R Wild type strain ATCC927 
M. marinum 8G10 Transposon mutant, MMAR0978 promoter::Tn5371 HygR This study 
M. marinum 8G10/pMV261 Transposon mutant, MMAR0978 promoter::Tn5371, 
transformed with vector pMV261, HygR and KanR 
This study 
M. marinum 8G10/ 
pMV261MMAR0978 
Transposon mutant, MMAR0978 promoter:: Tn5371, 
complemented with pMV261MMAR0978, HygR and 
KanR 
This study 
M. marinum 8G10/ 
pMV261Rv0643c 
Transposon mutant, MMAR0978 promoter:: Tn5371, 
complemented with pMV261Rv0643c (methoxy mycolic 
acid synthase 3 in M. tuberculosis H37Rv), HygR and 
KanR 
This study 
4.2.2 Complementation of M. marinum 8G10 
MMAR0978 was PCR-amplified from M. marinum 1218R genomic DNA using 
the primers MMAR0978-F (5´-CGCGGATCCAATGTCCGGTAAAGCAGTAGC-3´) 
and MMAR0978-R (5´-CCCAAGCTTCTACTTGGCCAGAGTGAACT-3´). The 
complementation plasmid pMV261MMAR0978 was obtained by cloning 
BamHI-HindIII digested PCR product (sites incorporated in the primers are 
underlined) into pMV261. A similar approach was used to construct pMV261Rv0643c, 
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the complementation plasmid containing the M. tuberculosis homologue: Rv0643c 
was PCR amplified from M. tuberculosis H37Rv genomic DNA using the primers 
Rv0643-F (5´-CCGGAATTCATGTCTGATAACTCAACGGGC-3´) and Rv0643-R 
(5´-CCCAAGCTTTCTACTTGGCCAGCGTGAAC-3´) and cloned into the 
EcoRI-HindIII digested pMV261. Electroporation of M. marinum 8G10 was 
performed as described in the general protocols for mycobacteria by Larsen et al 
(Larsen et al., 2007) and the complemented strains were obtained following 
electroporation of M. marinum 8G10 with pMV261MMAR0978 and pMV261Rv0643, 
respectively. 
4.2.3 Extraction and culturing of murine bone marrow derived macrophages 
Mouse (Balb/c) were sacrificed and the skin removed from the lower part of the 
body. Tissue was removed and legs were dissected. The pelvic and femoral bones 
were cleaned and separated at the knee joint. The bone was cut off at each end and  
bone marrow was expelled with 5ml of bone marrow medium (Dulbecco’s modified 
Eagle’s medium [DMEM], supplemented with 4.5g/L glucose, L-glutamine , pyruvate 
and 10% heat-inactivated fetal bovine serum [FBS]), from both ends by using a 
syringe. Cells were collected and harvested by centrifuging at 1,500rpm for 5 minutes. 
Cells were resuspended gently in 10ml of fresh DMEM and gently aspirated to break 
down cell aggregates. The cell suspension was adjusted to 106cells/ml and seeded into 
12 well plates with 106cells/well. Cells were incubated for 5-7 days at 37°C under 
10% (v/v) CO2 and were fed every 2-3 days. The medium was changed on day 6. 
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4.2.4 Macrophage infections 
Late log phase bacteria were washed with PBS and resuspended in infection 
medium (DMEM with 10% FBS) to 107cfu/ml. Murine bone marrow macrophages 
were infected by M. marinum with MOI of 10 and incubated at 37°C under 10% (v/v) 
CO2 for 2-4 hours. The infection medium was removed and the cells were washed 
twice with PBS and once with complete medium (DMES with 10% FBS and 50μg/ml 
gentamicin). Cells were incubated in 1ml complete medium at 37°C under 10% (v/v) 
CO2 overnight. On Day 1, the supernatant was removed and cells were washed once 
with PBS. Fresh complete medium without gentamicin was added. Cells were 
incubated at 37°C under 10% (v/v) CO2 for 1 hour. The supernatant was collected as 
Day 1 for future cytokine studies and cells were lysed with 1ml of PBS with 0.1% 
TritonX-100. Samples were collected on Day 3 and Day 5. The infection medium and 
cell lysates were 10 fold serial diluted and plated out on 7H10 agar plates. The plates 
were incubated at 30°C for 1 week before counting colonies (cfu). Survival 
percentage was calculated using 100×(cfuDayX/cufInfection). Each experiment was 
repeated in triplicate. 
4.2.5 Construction of a M. marinum strain encoding dsRed for visulisation in 
zebrafish embryo 
pMSP12-dsRed-Apr: aacC41 gene was amplified from plasmid pMV261-Apra 
(with primers: 5’CCAATGCATATGGGCACTCGGCATAGGCGAGTG3’ and 
5’CCAATGCATATGGTGGATCCCCCGTGTTGCCCC3’, ) and cloned into NsiI 
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digested vector pMSP12-dsRed. After transformation into E. coli TOP10, cells were 
selected on LB agar with 30μg/ml apramycin at 37°C, overnight.  
4.3 Results 
4.3.1 Colony morphology of M. marinum 8G10 Tn-mutant 
As described in Chapter 2, the strain 8G10 was isolated from a Tn-mutant library 
of M. marinum, as a mutant with altered colony morphology. The most apparent 
changes for 8G10 were observed on 7H10 agar plates that contained Tween 80 as 
shown in Fig. 4.1, with a smoother and glossier surface compared to the wild type 
strain. 
4.3.2 Effect of mmaA3 on M. marinum mycolic acid profile 
Sequencing of the Tn5371 insertion site in 8G10 mutant revealed that the Tn 
inserted into the promoter region, upstream of MMAR0978 encoding a mycolic acid 
Fig. 4.1 Single colony morphology of M. marinum 8G10 mutant on 7H10 
agar (with or without 0.05% Tween 80). Late-log phase culture was 
streaked out on agar plate and then incubated at 30°C to form single colony. 
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O-methyl transferase similar to Rv0643c, a homologue found in M. tuberculosis 
responsible for the biosynthesis of methoxymycolic acids. This suggested that the 
observed alteration in colony morphology was likely due to disruption of transcription 
of MMAR0978, thus affecting MMAR0978 function. It could cause the loss of 
methoxymycolic acid production that might change the lipid and mycolic acid profile 
and alter the colony morphology. Initially, total lipid analysis by 2D-TLC revealed no 
substantial change in the mutant’s non-polar and polar lipid profiles compared with 
wild type M. marinum (Fig. 4.2A). However, analysis of the sub-classes of mycolates 
from the mutant revealed a dramatic decrease in methoxymycolate production (Fig. 
4.2B). This defect could be complemented by introduction of a pMV261-cloned copy 
of M. marinum mmaA3 (MMAR0978) and the M. tuberculosis homologue (Rv0643c), 
respectively. Both complementation experiments restored methoxymycolate synthesis 
more than wild type levels with less ketomycolate than the wild type (Fig. 4.2B). 
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4.3.3 Effect of loss of methoxymycolic acids on M. marinum virulence 
To assess the virulence of the methoxymycolic acid deficient mutant, an 
intracellular survival assay using murine bone marrow macrophages was performed. 
The results showed no distinct differences between wild type M. marinum and the 
mutant suggesting no changes in the ability to replicate in macrophages (Fig. 4.3). 
 
Fig. 4.2 Lipid and mycolic acid analysis of M. marinum 8G10 mutant and the 
complementation strains. A. 2D-TLC of non-polar and polar lipids of M. marinum. B. 1-D 
TLC analysis of MAMEs of M. marinum. 1-M .marinum wild type; 2-M. marinum 8G10; 
3-M .marinum 8G10/pMV261MMAR0978; 4-M .marinum 8G10/pMV261Rv0643c. Ac2PIM2 
and AcPIM2 di- and monoacyl phosphatidylinositol dimammosides, Ac2PIM6 and AcPIM6 di- 
and monoacyl phosphatidylinositol hexamammosides, LOS-I LOS-II LOS-III and LOS-IV 
lipooligosaccharide I II III and IV, PI phosphatidyl inositol, PDIM phthiocerol dimycocerosate 
PGL phenolic glycolipid, PL phospholipid, TDM trehalose dimycolates, TMM trehalose 
monomycolates, TAG triacylglycerol, MAME mycolic acid methyl ester. 
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Given that this cultured macrophage can only represent an intracellular 
environment during disease progression, but not the complete host immune system, 
the zebrafish infection model was used to examine if there would be any difference in 
terms of virulence. E. coli-mycobacterial shuttle plasmid containing dsRed, 
pMSP12-dsRed-Apr, was electroporated into M. marinum wild type, 8G10 Tn-mutant 
and two complemented strains to generated Red fluorescence-labeled bacteria. These 
red fluorescence-labeled bacteria were then used for infection in order to observe the 
spread of the bacteria in real-time and the amount of living bacteria could be 
quantified by the increase of red fluorescence. A representative experiment is shown 
in Fig. 4.4, five days after infection, strong red fluorescence was detected in zebrafish 
embryos infected with wild type M. marinum from head to tail, suggesting that the 
bacteria survived and disseminated all over the embryo, while only weak fluorescence 
could be seen in embryos infected with the 8G10 mutant, representing less live 
bacteria in the zebrafish embryos. This experiment is currently being repeated to 
confirm the initial data and adult zebrafish will also be used for infection studies to 
Fig. 4.3 Survival of M. marinum in murine bone marrow macrophages 
Chapter 4 Impact of Mycolic Acid Modification on the Virulence of Mycobacterium marinum 
 97
examine the formation of granulomas.  
 
4.4 Discussion 
M. tuberculosis has a special lipid-rich cell wall providing protection from harsh 
environments which is crucial for the successful infection process. As the outmost 
part of the bacilli, the cell wall components are the first things encountered by host 
cells during infection; therefore, they play important roles in disease progression. 
Several cell wall components, such as TDM and LAM, have been identified as 
immunomodulators (Guerardel et al., 2003; Kan-Sutton et al., 2009). Information of 
how mycobacterial cell wall components interact with the host immune system can 
help understand the disease and provide clues for the development of novel drugs as 
well as vaccines.  
Based on the hypothesis that a change of cell wall composition will lead to a 
change in colony morphology, the M. marinum Tn-mutant library was screened for 
Fig. 4.4 Real-time analysis of M. marinum infection in zebrafish embryos  
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colony morphology altered mutants. From the 20 Tn-mutants with altered colony 
morphology, the MMAR0978 promoter disrupted mutant was chosen for further study. 
From the annotation data, MMAR0978 was in the region of genes involved in mycolic 
acid biosynthesis. Its homologue in M. tuberculosis was Rv0643c (mmaA3), an 
O-methyltransferase responsible for transferring a methyl group from SAM to form 
methoxymycolic acids. Although, the Tn insertion of the mutant was in the promoter 
but not the gene itself, it blocked the function of MMAA3 confirmed by FAMEs and 
MAMEs analysis that the production of methoxymycolate decreased dramatically in 
the mutant and was restored by complementing the mutant with MMAR0978 and its M. 
tuberculosis homologue Rv0643c, respectively, indicating that these two genes shared 
the same function. As shown in Fig. 4.2B, there was altered mycolate composition, 
increased methoxymycolates and decreased ketomycolates, as described previously 
(Yuan & Barry, 1996). This may be due to the fact that pMV261 is a multi-copy 
plasmid, which causes overexpression of mmaA3 and leads to the overproduction of 
methoxymycolic acids. As keto and methoxymycolic acids share the same precursor 
(Dubnau et al., 2000), this causes a decrease of ketomycolic acid production. 
In both M. tuberculosis and M. marinum, there are three sub-classes of mycolic 
acids based on the modification on the mero-chain, α-, methoxy and keto (Barry et al., 
1998). The last two are also known as oxygenated mycolic acids and share the same 
precursor in biosynthesis (Dubnau et al., 2000). It has been reported that the loss of 
both keto and methoxymycolic acids in M. tuberculosis leads to a decrease in cell wall 
permeability to small molecules and growth in a mouse model. Recent research 
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suggests that these oxygenated mycolic acids play an important role in macrophages 
differentiating into lipid-accumulated foamy macrophages, which are found in 
granulomas and may be the nutrient source for the bacilli in the persistent phase of 
growth (Peyron et al., 2008). However, the loss of methoxymycolic acids was 
reported and related to the attenuation of M. bovis BCG and the restoration of 
methoxymycolic acids made no difference in M. bovis BCG sensitivity to antibiotics 
and survival in macrophages, as well as in mice (Belley et al., 2004). Given the 
situation that M. bovis BCG has lost the virulence related RD1 during the first phase 
of attenuation; it is difficult to draw any conclusions that methoxymycolic acids are 
unrelated to virulence. Besides, up till now, there is no research evaluating the 
virulence using keto or methoxymycolic acids, respectively, in pathogenic 
mycobacteria. Thus, this methoxymycolic acid deficient M. marinum 8G10 mutant 
isolated in this study provided an opportunity to study the effects of loss of 
methoxymycolates on virulence in a strain that still produced comparable levels of α- 
and ketomycolates. 
Intracellular growth in macrophages and survival from acid stress, as well as 
oxidative stress are crucial for virulence. No difference was found between the wild 
type M. marinum and the methoxymycolic acid deficient 8G10 Tn-mutant in the 
murine bone marrow macrophage infection assay. Considering that cultured 
macrophages can only partially mimic the intracellular environment but not infection 
in the context of the complete host immune system and that intracellular survival is 
just the start of successful infection of the disease, a different animal model of 
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infection and granuloma formation in an intact host was examined. 
M. marinum is a fish pathogen and has similar mycolic acid components as M. 
tuberculosis. Recently, the M. marinum-zebrafish infection model was used for 
pathogen-host studies (Pozos & Ramakrishnan, 2004; Stamm & Brown, 2004). As 
one of the natural hosts of M. marinum, the zebrafish infection model has one specific 
advantage, the formation of granulomatous lesions which are similar to TB infection 
in humans. Therefore, the zebrafish was used for virulence studies using the 
methoxymycolic acid deficient 8G10 Tn-mutant. The initial data showed that the wild 
type M. marinun could successfully survive, replicate and further migrate within the 
zebrafish embryos five days after infection, whilst the majority of the 
methoxymycolic acid deficient 8G10 mutant was eliminated. These preliminary 
results indicated that the loss of methoxymycolic acids may cause the attenuation of 
M. marinum in terms of infecting zebrafish embryos.  
Recent studies demonstrate that oxygenated mycolic acids, which include 
methoxymycolic acids, can induce the differentiation of macrophages to foamy 
macrophages, which are found in granulomas. These foamy macrophages are not only 
involved in the cavitation of granulomas which leads to the release of living bacilli 
but also as a reservoir for bacilli persistence in TB patients (Peyron et al., 2008; 
Russell et al., 2009). Considering that the studies refer to oxygenated mycolic acids as 
a whole group, including keto, methoxy and hydroxyl-mycolic acids, methoxymycolic 
acids may be involved in the later stage of TB progression, such as persistence or 
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granuloma formation/destruction. Given that zebrafish embryos have not developed 
an adaptive immune system, only the innate immune response is involved in this 
infection model. However, adult zebrafish, which have both innate and adaptive 
immune systems, would be used for the aims mentioned above in future studies. 
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5.1 Introduction 
Three major carbon metabolism pathways have been reported in prokaryotic 
organisms, which are the citric acid cycle (also known as tricarboxylic acid or TCA 
cycle), and two anaplerotic pathways, the glyoxylate cycle and the methycitrate cycle. 
The TCA cycle is essential in cell metabolism and in eukaryotes. It uses acetyl-CoA 
derived from carbon sources, such as sugars and fatty acids, to provide reducing 
equivalents for energy and also intermediates for the biosynthesis of some amino 
acids. As for prokaryotes, under anaerobic conditions or limited carbon sources, the 
glyoxylate cycle and methylcitrate cycle are involved in replenishing intermediates 
for TCA cycle (Fig. 5.1). Isocitrate dehydrogenase (ICD) is one of the key regulatory 
enzymes in the TCA cycle and is located at the junction between the TCA cycle and 
the glyoxylate cycle. It is responsible for catalysing oxidative decarboxylation of 
D-isocitrate to α-ketoglutarate (α-KG) and CO2, using NAD+ or NADP+ as a cofactor. 
In E. coli, the activity of ICD is regulated by a bi-functional isocitrate dehydrogenase 
kinase/phosphatase, AceK, from the glyoxylate operon. ICD is inactivated by 
phosphorylation resulting in isocitrate flux through the glyoxylate bypass (LaPorte, 
1993; Zheng & Jia, 2010), which is important for bacteria when growing under sole 
carbon sources, such as acetate (El-Mansi et al., 2006). 
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While playing an important role in central metabolism, the TCA cycle and 
associated bypass pathways also play an important role in the ability of pathogenic 
bacteria to survive inside the infected host. The product of ICD in the TCA cycle, 
Fig. 5.1 Citric acid cycle and related anaplerotic pathway. The bifurcated biosynthetic mode 
of operation of the citric acid cycle, comprising oxidative (blue) and reductive (red) branches, is 
employed by bacteria growing under aerobic conditions in excess glucose or anaerobically on any 
carbon substrate, and by bacteria that lack KDH/KGD. Some intermediates of glycolysis and the 
citric acid cycle (boxed) are also diverted into biosynthetic pathways. Depleted intermediates are 
replenished via anaplerotic reactions (green), catalysed by PPC or PCA during growth on excess 
carbohydrate, or by ICL and MLS during growth on fatty acids or limiting carbohydrate. MEZ, 
malic enzyme; PPC, PEP carboxylase; PCK, PEP carboxykinase; PPS, PEP synthase; PPDK, 
pyruvate phosphate dikinase; PYK, pyruvate kinase; PCA, pyruvate carboxylase; PDH, pyruvate 
dehydrogenase; CIT, citrate synthase; ACN, aconitase; IDH, isocitrate dehydrogenase; KGD, α 
-ketoglutarate decarboxylase; SSADH, succinic semialdehyde dehydrogenase; KDH, α 
-ketoglutarate dehydrogenase; SUC, succinyl-CoA synthetase; SDH, succinate dehydrogenase; 
FRD, fumarate reductase; FUM, fumarase; MDH, malate dehydrogenase; MQO, malate:quinone 
oxidoreductase; ICL, isocitrate lyase; MLS, malate synthase; BOC, β -oxidation cycle; MCC, 
methylcitrate cycle. (Munoz-Elias & McKinney, 2005) 
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α-KG, has been recently reported to have a role in the detoxification of reactive 
oxygen species (ROS), such as hydrogen peroxide and superoxide (Mailloux et al., 
2007). In addition, NADP+-dependent ICD is also one of the resources of the critical 
molecule NADPH. It is the common co-factor as electron donor in various 
mechanisms of detoxification, for example in the reduction of NO- to NO3 by Fhb1 
(Gardner et al., 2000) and demutation of H2O2 to O2 and water by catalase (Kirkman 
& Gaetani, 1984; Sadecky et al., 1975). Meanwhile, NADH, the cofactor of 
NAD+-dependent ICD, acts as a pro-oxidant. The ratio of NAD+ and NADH 
determines the rate of superoxide (one species of ROS) formation. NADH:ubiquinone 
oxidoreductase (complex I) plays a significant contribution in cellular oxidative stress 
as a major source of superoxide in mitochondria. Research, using complex I isolated 
from bovine heart mitochondria, shows superoxide is produced by transferring 
electrons from reduced flavin to O2. The rate is determined by the portion of 
competent flavin which is set by a pre-equilibrium and controled by the dissociation 
constants of NADH and NAD+, as well as, the reduction potentials of flavin and 
NAD+ (Kussmaul & Hirst, 2006). Studies in E. coli demonstrate that the ICD 
knock-out mutant is more susceptible to oxidative stress (Kriakov et al., 2003). 
However, studies in Cryptococcus neoformans, an opportunistic fungal pathogen, 
suggests that ICD is important for resistance to nitrosative stress but not oxidative 
stress (Brown et al., 2010). 
M. tuberculosis is an intracellular bacterium that can replicate and survive in 
macrophages (Vergne et al., 2004). The mechanisms of its survival in macrophages 
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and its ability to circumvent the immune defence have been studied for some time. 
Modulation of the immune response by mycobacterial cell wall components (Pieters, 
2008) includes arresting phagosome maturation (Fratti et al., 2003; Vergne et al., 
2005), evading intracellular oxidative stress (Bhatt et al., 2007; Gao et al., 2004; 
Piddington et al., 2001) and metabolic adaptation to the harsh intracellular 
environment (Boshoff & Barry, 2005; McAdam et al., 2002). It has been reported that 
M. tuberculosis metabolises fatty acids rather than carbohydrates (Boshoff & Barry, 
2005) The expression of genes involved in fatty acid metabolism increase in vivo 
(Dubnau & Smith, 2003), indicating anaplerotic pathways are important for in vivo 
growth. Isocitrate lyase (ICL) is the first enzyme in the glyoxylate shunt, an 
anaplerotic pathway for the TCA cycle to help replenish intermediates in certain 
environments, such as using acetate as the only carbon source. In M. tuberculosis two 
icls (icl1 Rv0647, and icl2a/b Rv1915-Rv1916) have been reported and both are 
required for in vivo growth and virulence (Munoz-Elias & McKinney, 2005). 
However, icl1 shows more virulence related functions compared to icl2. Firstly, only 
the loss of icl1 causes the defect in persistence of the bacilli in a chronic infection 
mouse model (Munoz-Elias & McKinney, 2005). Secondly, icl1 can also function as 
2-methylisoitrate lyase (mcl), an enzyme in the methylcitrate shunt, which is 
important for utilising propionyl-CoA, a product of the β-oxidation of odd-chain fatty 
acids when using fatty acids as a carbon source (Gould et al., 2006). Besides, M. 
tuberculosis also shows several unique features in terms of the composition of its 
central carbon metabolism pathways. Biochemical experiments on the TCA cycle 
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enzyme activities have shown that M. tuberculosis lacks α-ketoglutarate 
dehydrogenase (KDH) which is responsible for decarboxylation of α-ketoglutarate, 
producing succinyl-CoA. Instead, it uses α-ketoglutarate decarboxylase (KGD), and 
succinic semialdehyde dehydrogenase (SSADH) to produce succinate directly (Fig. 
5.1) (Munoz-Elias & McKinney, 2005; Tian et al., 2005a; Tian et al., 2005b). In 
addition, two ORFs (Rv3339c-icd1, Rv0066c-icd2) in the M. tuberculosis genome are 
annotated as genes encoding isocitrate dehydrogenases. Protein sequence alignment 
shows that M. tuberculosis ICD1 is closer to eukaryotic NADP+-dependent ICDs, 
while ICD2 clusters with other prokaryotic NADP+-dependent ICDs (Banerjee et al., 
2005; Steen et al., 2001). Both of them have been confirmed to be functional in in 
vitro enzymatic assays (Banerjee et al., 2005) and reported to be able to elicit a B cell 
response in TB patients, respectively (Banerjee et al., 2005). Interestingly, most 
pathogenic mycobacteria, like M. bovis, M. tuberculosis and M. marinum, have two 
icds annotated, while non-pathogenic mycobacteria, like M. smegmatis, have only 
one. 
The studies described in this chapter were initiated by the isolation of a M. 
smegmatis Tn-mutant 3D9 with an insertion in icd (MSMEG1654) which displayed an 
apparent altered colony morphology on 7H10 agar plates (either with or without 
Tween 80). Given the role of icd in central carbon metabolism and the utilisation of 
fatty acids as a carbon source in Mycobacterium, it was presumed that the 3D9 mutant 
appeared to have altered colony morphology due to defects in cell wall lipid content, 
resulting in a perturbed carbon flux in cells. The first aim of this study was to identify 
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alterations in the cell wall lipid components. Additionally, the availability of a M. 
smegmatis icd mutant provided an opportunity to study the role of this enzyme in the 
above mentioned processes that are essential for virulence. Furthermore, given that M. 
smegmatis has only one icd gene, this mutant was an ideal surrogate to transform with 
different orthologues of M. tuberculosis icds to test for functional complementation. 
The main aims of this study were to (1) assess the effects of icd inactivation on 
mycobacterial lipid biosynthesis; (2) demonstrate functionality for both icd 
orthologues from M. tuberculosis by the use of enzymes assays with extracts from 
complemented strains and (3) study the effects of icd in terms of anti oxidative stress, 
nitrosative stress and acid stress. 
5.2 Materials and Methods 
5.2.1 Bacterial strains and plasmid growth conditions 
Bacterial strains, plasmids, and phages used in this study are listed in Table 5.1. 
M. smegmatis was grown in TSB with 0.05% Tween 80 at 37°C and E. coli in LB 
broth at 37°C. The antibiotics hygromycin and kannamycin were added at 
concentrations of 100μg/ml and 25μg/ml, respectively, for M. smegmatis and 
150μg/ml and 50μg/ml for E. coli, where required. Enriched mineral salt agar 
(Na2HPO4 3.57g/L, KH2PO4 1.5g/L, NH4Cl 1.0g/L, MgSO4·7H2O 0.2g/L, CaCl2·2 
H2O 20.0mg/L, Fe(III)NH4-Citrate 1.2mg/L, NaCl 0.85g/L pH 7.0, 1.5% agar w/v) 
supplemented with 0.1% glycerol, 0.1% glucose, 0.1% potassium acetate, 0.002% 
oleic acid or 0.002% palmitic acid was used for single carbon source test for M. 
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smegmatis. 
Table 5.1 Plasmids and Bacterial strains used in this study 
Strains or Plasmids Discription Source or Reference 
Plasmid   
pMV261 E.coli-mycobacterial shuttle plasmid, 
KanR 
(Stover et al., 1991) 
pMV261MSMEG1654 MSMEG1654 cloned in pMV261, KanR This study 
pMV261Rv3339c Rv3339c cloned in pMV261, KanR This study 
pMV261Rv0066c Rv0066c cloned in pMV261, KanR This study 
Bacteria   
E.coli Top10   
M. smegmatis mc2155 Parental (wild type strain) strain, Ept 
mutant 
(Snapper et al., 1990) 
M. smegmatis 3D9::Tn5371 Transposon mutant, MSMEG1654:: 
Tn5371 HygR 
This study 
M. smegmatis 3D9/pMV261 Transposon mutant, MSMEG1654:: 
Tn5371, transformed with vector 
Pmv261, HygR and KanR 
This study 
M. smegmatis 
3D9/pMV261MSMEG1654 
Transposon mutant, MSMEG1654:: 
Tn5371, complemented with 
pMV261MSMEG1654, HygR and KanR 
This study 
M. smegmatis 3D9/ 
pMV261Rv3339c 
Transposon mutant, MSMEG1654:: 
Tn5371, complemented with 
pMV261Rv3339c(icd1 in M.tuberculosis 
H37Rv), HygR and KanR 
This study 
M. smegmatis 
3D9/pMV261Rv0066c 
Transposon mutant, MSMEG1654:: 
Tn5371, complemented with 
pMV261Rv0066c(icd2, homologue in 
M.tuberculosis H37Rv), HygR and KanR 
This study 
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5.2.2 Growth curve and viability test 
Fresh cultures of M. smegmatis were diluted in TSB with 0.05% Tween 80 
(antibiotics were added where required) to OD600=0.1 and incubated at 37°C shaking 
at 180 rpm. The growth of cultures was monitored by OD600 every 6 hours. At every 6 
hour monitoring point, 0.5ml culture was collected and a viability test conducted. 
Each sample was ten-fold serially diluted in TSB upto 10-6 and 10μl of each dilution 
was spotted on a TSB agar plate. Samples were performed in triplicate. TSB agar 
plates were incubated at 37°C for 2-3 days, and single colonies counted for 
calculating cfu/ml (colony forming units per ml) at each time point. 
5.2.3 Preparation of bacterial lysate for assaying ICD activity 
A mycobacterial cell pellet from a 5L culture was resuspended in 5ml of Buffer A 
(MOPS 50mM pH 7.9 with KOH, MgCl2 10mM, β-mercaptomethanol 5mM) and 
sonicated with 60 sec on and 90 sec off, 10 cycles. After centrifugation (27,000g, 30 
min, 4°C), the supernatant was collected and centrifuged (100,000g, 3 hours, 4°C). 
The supernatant was collected and the protein concentration was determined using the 
BCA protein assay (Thermo scientific, Pierce). 
5.2.4 Enzyme assay for isocitrate dehydrogenase 
An isocitrate dehydrogenase enzyme assay was performed as described (Tian et 
al., 2005a). The reaction mixture (1ml) contained 50mM HEPES (pH 8.0), 0.25mM 
NADP+, 10mM MgCl2, 1 mM isocitrate and M. smegmatis whole cell lysate (50μg 
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protein). The reaction was monitored by production of NADPH at 340nm. The 
extinction coefficient factor of 6223M-1·c m-1 was used to calculate rate. 
5.2.5 Assay of acid sensitivity 
Mid-log-phase bacterial cultures were washed with pic-Ty-4.5 (phosphate-citrate 
buffer pH 4.5, tyloxapol 0.02% v/v). Cells were suspended in pic-Ty-4.5 at ~5×106 
cfu/ml and incubated at 37°C for 1, 2 and 3 doubling times. Viable cell numbers were 
determined by plating 10-fold serial dilutions of the cell suspension on TSB (for M. 
smegmatis). 
5.2.6 Assay for oxidative stress 
Late-log-phase bacterial cultures were mixed with molten 7H9 soft agar (50°C) 
and overlaid onto 7H9 agar plate. After the softer agar was solidified, a paper disc 
(diameter: 6mm) soaked with H2O2 (60mM and 100mM) was attached to the surface. 
Plates were incubated at 37°C to form inhibition zones. 
5.2.7 Assay for nitrosative stress 
Late-log-phase bacterial cultures were 10-fold diluted in PBS and spotted onto 
7H9 agar plates containing different concentrations of sodium nitrite (0mM, 2.5mM, 
5mM. 10mM). Plates were incubated at 37°C for 3 days.  
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5.3 Results 
5.3.1 Colony morphology changes of the M. smegmatis 3D9 mutant 
As described in Chapter 2, the strain 3D9 was isolated from a Tn-mutant library 
of M. smegmatis, as a mutant with altered colony morphology. The most apparent 
changes of 3D9 were observed on 7H10 agar plates (either with or without Tween 80) 
in single colony morphology as shown in Fig. 5.2. Compared to the wild type strain, 
on 7H10-T agar, 3D9 mutant had a smoother surface on 7H10-T agar, but a smaller 
colony with a smoother surface on 7H10 agar plates. 
 
Fig. 5.2 Colony morphology of M. smegmatis 3D9 mutant on 
different agar media (denoted on the left). A. 10μl spot of a 
stationary phase culture; B. Single colony of each Tn-mutant 
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5.3.2 Lipid analysis of M. smegmatis 3D9 mutant 
To identify changes (if any) in the lipid profiles of the M. smegmatis 3D9 mutant, 
wild type and mutant strains were labeled with [14C] acetate and analysed by TLC for 
polar lipids, non-polar lipids, fatty acids and mycolic acids. Both TSB (plus 0.05% 
Tween 80) and 7H10 (plus 0.05% Tween 80) broth were used for culturing. As shown 
in Fig. 5.3, no apparent differences were observed in any of these species.  
Fig. 5.3 Lipid and FAMEs/MAMEs analysis of M. smegmatis icd (3D9) mutant (TSB-T and 
7H10-T). A. 2D-TLC analysis of non-polar and polar lipids. B. 1-D TLC analysis of 
FAMEs/MAMEs. 1-M. smegmatis wild type, 2-M. smegmatis 3D9. Ac2PIM2 and AcPIM2 di- and 
monoacyl phosphatidylinositol dimannosides, Ac2PIM6 and AcPIM6 di- and monoacyl 
phosphatidylinositol hexamammosides, GPLs glycopeptidolipids, PI phosphatidyl inositol, PL 
phospholipid, TDM trehalose dimycolates, TMM trehalose monomycolates, TAG triacylglycerol; 
FAME fatty acid methyl ester, MAME mycolic acid methyl ester, 1- M. smegmatis wild type, 2- M. 
smegmatis 3D9 mutant 
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5.3.3 Growth characteristics of M. smegmatis 3D9 mutant 
Apparent colony morphology changes may often be a result of altered growth 
rates, rather than cell wall alterations. As mentioned above, isocitrate dehydrogenase 
participates in the TCA cycle which generates usable energy in form of ATP. Thus, it 
was likely that loss of ICD function in M. smegmatis may have affected growth. To 
test whether this was the case with the M. smegmatis 3D9 mutant, the growth rate of 
the mutant with that of wild type strain was compared. On examination of the growth 
curve it can be seen that compared with wild type strain, 3D9 mutant achieved a 
slower rate of growth (Fig. 5.4). When the mutant was complemented with the M. 
smegmatis icd gene, it showed the same growth pattern comparable to that of the wild 
type strain. 
Fig. 5.4 Growth curve of M. smegmatis wild type strain, 3D9 mutant and complemented 
strains. Fresh culture of M. smegmatis were diluted in TSB with 0.05% Tween 80 (antibiotics were 
added when required) to OD600=0.1 and incubated at 37°C shaking at 180rpm. The growth of the 
cultures was monitored by OD600 every 6 hours. 
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Thus, it was likely that the observed altered colony morphology was due to a 
slower growth rate, rather than an altered cell wall. The possibility remains that AG, 
LAM or capsular components of the mutant were altered and these remained to be 
analysed. However, this remains highly unlikely as alterations in these cell wall 
components are often fatal, or result in extremely drastic changes in colony 
morphology, none of which were observed in this mutant. 
5.3.4 The M. smegmatis 3D9 mutant as surrogate for studying mycobacterial icds  
 While the 3D9 mutant did not show any apparent cell wall alterations, it still 
presented an opportunity to study ICD in a mutant background, and as a surrogate for 
the M. tuberculosis orthologues. Unlike non-pathogenic mycobacteria which have 
only one icd in their genome, M. tuberculosis and some other pathogenic 
mycobacteria have two copies. Phylogenetic analysis based on protein sequence 
reveals that M. tuberculosis ICD1 is much closer to eukaryotic ICDs (Fig. 5.5 A) 
(Banerjee et al., 2005) while M. tuberculosis ICD2 is closer to prokaryotic ones (Fig. 
5.5 B) (Steen et al., 2001). However, both of them are NADP+-dependent with 
different physio-chemical properties, such as ionic cofactor, optimal pH and 
temperature for activity in vitro (Banerjee et al., 2005). Current bioinformatics and 
enzymology data indicates that it is highly possible these two icd genes in M. 
tuberculosis may overlap in function in the TCA cycle while play different roles under 
different conditions. The two M. tuberculosis icd orthologues were amplified by PCR 
and cloned into the vector pMV261. Constructs were confirmed by sequencing before 
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used in further studies with the M. smegmatis 3D9 mutant for functional 
complementation.  
 
Fig. 5.5 Phylogenic analysis of M. tuberculosis ICD1 and ICD2 (Banerjee et al., 
2005). A. ICD1 B. ICD2 
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5.3.5 The M. smegmatis 3D9 mutant as surrogate for studying mycobacterial icds: 
restoration of growth pattern in different carbon sources 
To test for functional complementation with the M. tuberculosis icd orthologues, 
the growth curve of the wild type, 3D9 mutant and complemented strains were 
examined. Results showed that M. smegmatis 3D9 mutant complemented with M. 
tuberculosis icd2 had a similar growth pattern as the wild type strain, while the mutant 
complemented with M. tuberculosis icd1 still grew more slowly than the wild type 
strain but faster than the mutant (Fig. 5.4). The ability of the 3D9 mutant to grow on 
single carbon sources, such as sugars and fatty acids, and to observe whether the loss 
of ICD in M. smegmatis would affect the use of different carbon sources was 
examined. Results showed that when using either glycerol, glucose, acetate, oleic acid 
or palmitic acid as only carbon source, respectively, M. smegmatis wild type strain 
could grow as normal while the 3D9 mutant and the mutant transformed with 
pMV261 vector could not. When the mutant was complemented with M. smegmatis 
icd or M. tuberculosis icd1/icd2, its ability to grow on each carbon source was 
restored comparable to the wild type strain (Fig. 5.6). 
Fig. 5.6 Growth of M. smegmatis icd mutant and complementation strains on minimum 
medium with only carbon source 1-M. smegmatis wild type; 2-M. smegmatis 3D9, 3-M. 
smegmatis 3D9/pMV261, 4- M. smegmatis 3D9/pMV261MSMEG1654, 5- M. smegmatis 
3D9/pMV261Rv0066c, 6- M. smegmatis 3D9/pMV261Rv3339c. 
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5.3.6 The M. smegmatis 3D9 mutant as surrogate for studying mycobacterial icds: 
restoration of ICD activities in M. smegmatis lysates 
To detect the isocitrate dehydrogenase activity directly in M. smegmatis, whole 
cell lysates of wild type, 3D9 mutant and complemented strains were examined in an 
in vitro enzyme assay. From the results, no isocitrate dehydrogenase activity was 
detected in the M. smegmatis 3D9 mutant and the mutant with only pMV261 vector, 
whilst the mutant complemented with M. smegmatis icd showed high activity. 
Isocitrate dehydrogenase acitivity was also detected by using whole cell lysates of the 
M. smegmatis 3D9 mutant complemented with M. tuberculosis orthologues. Contrary 
to expectations, low activity was detected in the mutant complemented with M. 
tuberculosis icd2 which was the homologue of M. smegmatis icd. In addition, high 
background (without substrate isocitrate) was also detected compared with the wild 
type strain and other complemented strains, while the mutant with M. tuberculosis 
icd1 showed the highest activity, higher than that of the mutant with M. smegmatis icd. 
The enzyme activity dropped about 90% when MgCl2 was removed (Table 5.2). 
Table 5.2 ICD enzymatic activities in M. smegmatis wild type, 3D9 mutant and 
complemented strains 
Rate(μM·min-1·mg-1) 37°C 
Strain 
10mM MgCl2 No MgCl2 No Isocitrate 
M. smgmatis wild type 727.37 28.73 N/D 
M. smegmatis 3D9 N/D N/D N/D 
M. smegmatis 3D9/pMV261MSMEG1654 2162.62 328.20 N/D 
M. smegmatis 3D9/pMV261Rv0066c* 12.57 2.03 9.08 
M. smegmatis 3D9/pMV261Rv3339c 2574.13 658.14 N/D 
Reaction condition (1ml): 50mM HEPES (pH 8.0), 0.25mM NADP+, 10mM MgCl2, 1mM 
isocitrate and M. smegmatis whole cell lysate with 50μg protein, 37°C. *Whole cell lysate with 
500μg protein was used for M. smegmatis 3D9/pMV261Rv0066c  
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5.3.7 Optimal conditions for ICD activity 
As reported by Banerjee et al (Banerjee et al., 2005), M. tuberculosis ICD1 
(Rv3339c) and ICD2 (Rv0066c) both are functional enzymes but with different 
physio-chemical and kinetic properties. Both of them are NADP+-dependent. The 
eukaryotic clustered ICD1 can use both Zn2+ and Mg2+ as ionic cofactors, whilst the 
prokaryotic clustered ICD2 can only use Mg2+ with lower affinity as compared to 
ICD1. ICD1 has a wider range of pH for activity than ICD2. The ICD activity of cell 
lysates from different M. smegmatis strains used in this study were performed under 
different pH conditions as well as different concentrations of MgCl2. As shown in Fig. 
5.7, except M. smegmatis 3D9/pMVRv3339c (Fig. 5.7 D), the cell lysates from other 
three strains showed higher enzymatic activity with high concentrations of MgCl2 
(Fig. 5.7 A B C), which is consistent with the previous report that ICD1 has higher 
affinity with this cofactor. When different pH conditions were used for activity assay, 
lysates from M. smegmatis wild type (Fig. 5.7 A) and 3D9 mutant complemented 
strain with its own ICD (Fig. 5.7 B), demonstrated an increasing ICD activity along 
with an increase in pH. However, lysate of M. smegmatis 3D9/pMVRv0066c (the 
prokaryotic ICD2 in M. tuberculosis) showed higher ICD activity at low pH and 
decreased along with an increase of pH. Meanwhile, the ICD activity from lysate of M. 
smegmatis 3D9/pMVRv3339c (the eukaryotic ICD1 in M. tuberculosis) increased 
along with an increase of pH from 6.5 to 7.5 and started to decrease at pH 8.0. 
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5.3.8 Sensitivity of M. smegmatis mutant and complemented strains to oxidative 
and nitrosative stress 
It has been reported that ICD contributes to either anti-oxidative stress or 
nitrosative stress depending on species (Brown et al., 2010; Kriakov et al., 2003). 
Therefore, the sensitivity to oxidative stress using H2O2 was tested by comparing the 
diameter of the inhibition zone formed by a filter paper disc soaked with different 
concentrations of H2O2 on a lawn of each strain. Inhibition zones could be seen at 
40mM H2O2, but no distinctive difference between M. smegmatis wild type and 3D9 
mutant, or complemented strains (Table 5.3). 
 
Fig. 5.7 ICD enzymatic activities in M. smegmatis wild type strain and complemented icd 
mutant strains under different conditions M. smegmatis whole cell lysate with 50μg protein 
was used except M. smegmatis 3D9/pMV261Rv0066c (500μg). Data for M. smegmatis 3D9 
are not included because no ICD activity detected. 
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Table 5.3 Sensitivity to H2O2 of M. smegmatis mutant and complemented strains 
 Diameter of clear zone (cm) 
 60mM H2O2 100mM H2O2 
M. smgmatis wild type 1.0  1.2  
M. smegmatis3D9 1.2  1.4  
M. smegmatis3D9/pMV261MEMEG1654 1.0  1.4  
M. smegmatis3D9/pMV261Rv3339c 1.0  1.2  
M. smegmatis3D9/pMV261Rv0066c 1.2 1.4 
Discs soaked with different concentration of H2O2 solution were placed on bacterial lawn. 
Sensitivity was compared by the diameter of clear zone.  
Besides oxidative stress, the other mechanism macrophages adopt to eliminate 
bacterial infection is nitrosative stress. Studies in the fungal pathogen Cryptococus 
neoformans showed the importance of ICD in resistance to nitrosative stress rather 
than oxidative stress (Brown et al., 2010). Therefore, a sensitivity test to see whether 
ICD has a similar function in Mycobacterium was performed. As shown in Fig. 5.8, 
after 2 days, the growth of the 3D9 mutant was inhibited at 2.5mM NaNO2 by one log 
less compared to that of wild type strain and the three complemented strains, whilst, at 
higher concentration, the wild type strain was also inhibited. After 3 days, the growth 
defect of 3D9 mutant on plates containing NaNO2 was more distinct, suggesting that 
the loss of ICD activity may reduce the tolerance to nitrosative stress in M. smegmatis. 
Although the wild type strain can grew on plates containing 5mM or 7.5mM, it still 
showed one log less compared to complemented strains. Furthermore, on both day 2 
and day 3, the mutant complemented with M. tuberculosis icd2 grew better than the 
other two complemented strains. 
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5.3.9 Sensitivity of M. smegmatis mutant and complemented strains to acid stress 
Apart from oxidative/nitrosative stress, acid stress is another important strategy 
that a macrophage uses to eliminate engulfed pathogens. An in vitro assay was done to 
evaluate the sensitivity to acid stress of the M. smegmatis 3D9 mutant and 
complemented strains with different icd genes comparing to the wild type strain. 
Bacterial cells were incubated in phosphate-citrate buffer (pH4.5) at 37°C and 
samples were collected after one doubling time and twice the doubling time. Cells 
were counted by plating out serial dilutions on TSB agar plates. Results showed that 
more than 70% of the bacteria were killed at pH 4.5 after 8 hours for all strains; 
Fig. 5.8 Sensitivity of M. smegmatis 3D9 mutant and complemented strains to nitrosative 
stress (NaNO2) 
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however, no distinct differences between the wild type strain and the mutant, as well 
as mutant complemented strains with different icd gene were observed (Fig. 5.9). 
 
5.4 Discussion 
Although bacterial metabolic pathways have been studied for some time in the 
artificial environment of the laboratory, little was known about the metabolism of 
intracellular bacteria during infection (Munoz-Elias & McKinney, 2005). It was 
assumed that there should not be any differences between the metabolism of bacteria 
in vivo and in vitro. More recent studies have suggested that this may not be the case, 
since pathogenic bacteria use different nutrients and metabolic pathways during 
infection (Munoz-Elias & McKinney, 2005; Nathan, 2004). The TCA cycle is a 
central metabolic pathway in cells. The inactivation of icd in M. smegmatis resulted in 
a slow-growing phenotype in a rich medium (TSB) and disabled the growth in 
minimal media using glucose, glycerol or fatty acid as the sole carbon source. At the 
Fig. 5.9 Sensitivity of M. smegmatis 3D9 mutant and complemented strains to acid stress (pH 
4.5) 
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same time, there was no obvious change found in lipids, FAMEs and MAMEs. Thus, 
the effect of inactivation of ICD function on growth may be the reason for colony 
morphology change, but not on changes in cell wall components.  
ICL, the first enzyme of the glyoxylate cycle, has been found with two copies in 
M. tuberculosis and reported to be essential for in vivo growth and virulence (Gould et 
al., 2006; Munoz-Elias & McKinney, 2005). Similarly, two ICDs were annotated in 
the M. tuberculosis genome, as well as other pathogenic mycobacteria, but only one in 
non-pathogenic mycobacteria (Banerjee et al., 2005). It has been shown by in vitro 
enzymatic assays that both have identical function but different biochemical 
properties and phylogenic affiliations (Banerjee et al., 2005), which suggests that they 
may play different roles during growth stages and environmental adaptation. The 
complementation experiments revealed that under the same growth conditions, the 
function of M. smegmatis ICD could be replaced by M. tuberculosis ICD2, while only 
partially by M. tuberculosis ICD1. At the same time, results of enzymatic assays with 
whole cell lysates from the wild type, mutant and different complemented strains 
showed that: (1) the activity of M. tuberculosis ICD2 was much lower than that of M. 
tuberculosis ICD1 and that of M. smegmatis ICD in certain in vitro assay conditions, 
with high background when without isocitrate as a substrate; (2) M. tuberculosis ICD2 
had lower affinity to Mg2+ compared to M. tuberculosis ICD1 and M. smegmatis ICD, 
which was consistent with previous reports (Banerjee et al., 2005). 
It has been reported that ICD may be involved in anti-oxidative stress or other 
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harsh conditions, although the results in different species are not yet conclusive 
(Brown et al., 2010; Kriakov et al., 2003). Thus we studied the ability of the M. 
smegmatis wild type, 3D9 mutant and complemented strains with different icd genes 
to survive under, oxidative stress, nitrosative stress, and acid stress (pH 4.5), which 
are major mechanisms used by macrophages to kill bacteria. The results showed no 
differences between the wild type and the mutant, or complemented strains with 
different icd genes in terms of resistance to oxidative stress and acid stress, whilst the 
mutant was more susceptible to nitrosative stress compared to the wild type strain. 
Besides, a better tolerance of the complemented strains than that of wild type at 
higher concentrations of NaNO2 was also observed, which could be the result of over 
expression of different icds by the pMV261 vector, respectively, in complemented 
strains, similar to the situation found in the enzymatic assays. Interestingly, when 
comparing the three complemented strains with each other, the mutant complemented 
with M. tuberculosis icd2, the prokaryotic icd, showed an even better tolerance.  
In previous studies in the fungi pathogen, C. neoformans, several enzymes 
essential for survival from oxidative or nitrosative stress in macrophages have been 
identified (Chow et al., 2007; de Jesus-Berrios et al., 2003; Giles et al., 2006) and 
regardless of the mechanism, a common requirement for these enzymes to function is 
the cofactor NADPH as an electron donor. Further studies revealed that as one source 
of NADPH production, the ICD, which can be found in cytosol, peroxisomes or 
mitochondria, is important for resistance to nitrosative stress and suggests that it is the 
compartmentalisation of NADPH but not the recycling of oxidised antioxidants that is 
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critical for resistance (Brown et al., 2010). Although, M. tuberculosis is a prokaryote, 
it is still highly possible that the ICD-dependent NADPH production is the 
mechanism of resistance to nitrosative stress observed in this study. 
The M. smegmatis 3D9 mutant with a transposon insertion in icd provided a 
useful surrogate for studying the function of M. tuberculosis ICD orthologues in vivo. 
M. tuberculosis eukaryotic like ICD1 only partially complemented the mutant in 
growth rate but at the same level as the wild type strain in a nitrosative test, although 
it had a high enzymatic activity in an in vitro assay. On the other hand, the prokaryotic 
like ICD2 fully complemented the mutant in growth rate and gave better tolerance in 
the nitrosative test, whilst showed low activity in the in vitro assay. Although, no 
conclusion of the exact function of these two ICDs in M. tuberculosis infection can be 
drawn, these results indicate that these enzymes are involved in mycobacteral survival 
to nitrosative stress and that the function of these two ICDs, although different, often 
overlap. To further understand their roles in virulence and intracellular survival, 
specific knock-out strains of the two icds in M. bovis BCG will be made, respectively, 
and complemented with M. tuberculosis icds.  These strains should prove valuable 
resources for further probing the individual roles of the two icd orthologues in slow 
growing mycobacteria. 
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The distinct lipid-rich cell wall of mycobacteria can not only provide physical 
protection to the bacilli but can also play an important role in virulence. Several 
currently used anti-TB drugs target cell wall biosynthetic pathways. Thus a good 
understanding of the structure and biosynthesis of the cell wall will give helpful clues 
for the development of novel anti-mycobacterial drug targets, as well as a better 
understanding of mycobacterium-host cell interactions. 
The main objective of the studies reported in this thesis was to study cell wall 
biosynthesis in mycobacteria. To achieve this, a strategy based on random Tn 
mutagenesis with two different screening criteria, altered colony morphology and 
mycobacteriophage resistance, were adopted. Two model systems, non-pathogenic M. 
smegmatis and the fish pathogen M. marinum, were used for generating Tn-mutant 
libraries. M. smegmatis was used for both the colony morphology screen and 
mycobacteriophage resistance screen, whilst M. marinum was used only for 
morphology screen. A temperature sensitive phage with a mariner-based Tn5371 was 
used for Tn mutagenesis. The Tn insertion site was identified by sequencing and blast 
searching.  
By using different agar media (TSB, LB and 7H10, with or without Tween 80), 
eight mutants with colony morphology changes from the M. smegmatis Tn-mutant 
library were isolated. Among these mutants, two had Tn insertions in a gene cluster 
associated with cell division genes, pbpA (penicillin binding protein, MSMEG0031) 
and fhaA (MSMEG0035, forkhead-associated domain protein). PBPA has been 
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reported to be involved in PG biosynthesis and regulated by phosphorylation 
(Dasgupta et al., 2006), whilst the FHA domain can recognise phosphothreonine 
epitopes on proteins (Durocher & Jackson, 2002). Both of them are in the same 
operon together with a kinase PknB and a phosphatase PstP. The difference of 
morphology changes between these two mutants indicates different roles in cell 
division. Another mutant had a Tn insertion in GntR (MSMEG0268), a HutC-like 
sub-family regulator protein, which has been reported to respond to a number of 
molecules including long chain fatty acids and trehalose 6-phosphate (Allison & 
Phillips, 1990; Chen et al., 1990; Matthijs et al., 2000; Quail et al., 1994). Two 
disruptions were found in genes involved in metabolism, MSMEG1654 (isocitrate 
dehydrogenase, icd) and MSMEG6756 (glycerol kinase, glpK). It is highly likely that 
these metabolic pathways indirectly affect the biosynthetic pathways that contribute to 
cell wall components and it is also possible that central metabolic pathways can affect 
growth which further affects colony morphology. In addition, one mutant with a Tn 
insertion in an ABC transporter (MSMEG5102) and another two in unknown 
membrane proteins (MSMEG4256) and a hypothetical protein (MSMEG3327) were 
also isolated. 
By using 7H10 agar (with or without Tween 80), twenty M. marinum colony 
morphology mutants were isolated. Amongst the genes identified with a Tn insertion, 
five were involved in cell wall and cell processes, including (i) a hypothetical protein 
with a homologue of a probable membrane glycosyltransferase in M. tuberculosis 
(MMAR2327), (ii) a glycine betaine transport integral membrane protein 
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(MMAR2913), (iii) a lipoprotein LpqF (MMAR5092) whose homologue is essential 
for growth in M. tuberculosis but with a unknown function (Sassetti et al., 2003), (iv) 
a hypothetical protein with a unknown function (MMAR2352), and (v) a 
transmembrane protein (MMAR325) whose homologue in M. tuberculosis is required 
in survival in murine macrophages (Rengarajan et al., 2005). Six genes are involved 
in lipid metabolism. Three of them (MMAR1767, mas; MMAR1775, ppsB; 
MMAR1774, ppsC) are in the biosynthesis pathway of cell wall lipid/virulence factor, 
PDIM (Azad et al., 1997; Kruh et al., 2008; Mathur & Kolattukudy, 1992). Two genes 
are involved in the biosynthesis of fatty acid, a fatty acyl-AMP ligase (FadD28_1, 
MMAR1180) whose homologue in M. tuberculosis is responsible for production of 
monomethyl branched unsaturated fatty acids (Dubey et al., 2003) and a 
methoxymycolic acid synthase 3 (MMAR0978) involved in the modification of 
mycolic acids (Yuan & Barry, 1996). The last one is a fatty acyl-AMP ligase 
(MMAR2341, fadD25) that has been suggested involved in lipid degradation in M. 
tuberculosis (Betts et al., 2002). Besides, another two genes involved in intermediary 
metabolism and respiration, including a phytoene dehydrogenase (MMAR4806, crtI) 
involved in the biosynthesis of carotene that has protective functions against 
photo-oxidative damage (Runyon, 1959) and a serine protease (MMAR4214, htrA or 
degP), which might be essential for virulence in M. tuberculosis, were isolated. One 
virulence-related Esat-6-like protein (MMAR5449), one regulator (MMAR0992) and 
five hypothetical proteins with unknown function were also identified. 
Morphology screening used here for mycobacterial cell wall biosynthetic 
Chapter 6 General Discussion 
 131
pathways based on the hypothesis that changes in the composition of the cell wall 
components would alter the structure and then result in a different colony morphology. 
According to the results, two out of eight genes identified from the M. smegmatis 
Tn-mutants with altered colony morphology, were directly involved in cell wall 
biosynthesis, whilst eleven out of twenty in the M. marinum Tn-mutants. Although, 
the rest of them were not involved directly, they could affect cell wall components 
indirectly, such as intermediates for cell wall biosynthesis and transporters. Using a 
random approach based on morphology to screen for cell wall biosynthetic pathways 
can help to identify not only genes responsible for cell wall components but also 
genes which have an indirect impact, therefore providing more information for 
understanding cell wall biosynthesis as a whole picture. 
One mutant from each species was then selected for further studies as part of this 
study. As for M. smegmatis, the 3D9 (icd, MSMEG1654) mutant was selected, since, 
firstly, this enzyme involved in central metabolism pathways could also be involved 
in pathogenesis, such as icl (Munoz-Elias & McKinney, 2005). Secondly, compared 
to only one copy in non-pathogenic mycobacteria, pathogenic mycobacteria have two 
copies of icd indicating different functional roles, possibly related to virulence or 
intracellular survival. From the set of M. marinum mutants, the 8G10 (mmaA3, 
MMAR0978) mutant was chosen, as it was the homologue of mmaA3 for M. 
tuberculosis and was potentially involved in the biosynthesis of methoxymycolic 
acids. This provided an opportunity to study the role of methoxymycolic acids in 
virulence. 
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M. smegmatis 3D9 Tn-mutant had only icd gene disrupted and showed distinct 
colony morphology changes on 7H10 agar, however no difference was observed in its 
lipid profile when cultured in TSB, as well as 7H10 broth. Considering that icd is a 
key enzyme in central metabolism cycle, a growth test and a sole carbon source assay 
were performed and the results showed a slow-growth pattern compared to the wild 
type strain and a deficiency of growth on a single carbon source medium. Thus, the 
colony morphology change could be caused by the slow-growth pattern, rather than 
changes in cell wall components. Since there are two genes annotated as icd in M. 
tuberculosis, which have been confirmed with an enzymatic assay in vitro (Banerjee 
et al., 2005), the M. smegmatis 3D9 mutant was complemented with M. smegmatis icd, 
as well as both M. tuberculosis icds for functional studies in vivo. The results showed 
that both M. tuberculosis icds can complement the activity of M. smegmatis icd in 
both growth curve tests and sole carbon source assays, whilst the M. tuberculosis icd1 
(Rv3339c) could only partially complement the mutant in the growth curve test. To 
study further the enzymatic activity of ICD in complemented strains, an enzymatic 
assay using whole cell lysates was performed. The lysate of the complemented strains 
all had NADP+-dependent isocitrate dehydrogenase activity compared to the mutant, 
whilst lysates of both M. smegmatis icd and M. tuberculosis icd1 complemented 
strains showed higher activities than that of the wild type strain, which could be 
because of the overexpression of ICD by the multi-copy vector pMV261 used for 
complementation. Although, the lysate of M. tuberculoisis icd2 (Rv0066c) showed 
enzymatic activity, it was much lower than the wild type and the other two 
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complemented strains and also required more protein for the assays. Interestingly, 
according to phylogenetic analysis of these two M. tuberculosis icds, icd1 is closer to 
eukaryotic and icd2 closer to prokaryotic versions. The above results indicate that the 
two icds in M. tuberculosis might have different functions in terms of growth. ICD 
locates at the junction between the TCA cycle and the glyoxylate shunt. It controls the 
isocitrate flux between the TCA cycle and the glyoxylate shunt by 
phosphorylation/inactivation (LaPorte, 1993; Zheng & Jia, 2010). Studies in other 
species demonstrates that ICD can also be involved in the response to oxidative or 
nitrosative stress, which is important for intracellular pathogens to survive after 
phagocytosis by alveolar macrophages (Brown et al., 2010; Kriakov et al., 2003). In 
this study, the sensitivity to oxidative stress, nitrosative stress, as well as acid stress 
(pH 4.5) of the M. smegmatis wild type, mutant and different complemented strains 
was examined. There was no differences between the wild type and the mutant or 
complemented strains with different icd genes, in terms of resistance to oxidative 
stress and acid stress, whilst the mutant was more susceptible to nitrosative stress 
(NaNO2) compared to the wild type strain. Furthermore, better tolerance to higher 
concentrations of NaNO2 was observed in all the complemented strains and the strain 
with the M. tuberculosis icd2 (prokaryotic version of icd), showed an even better 
tolerance. 
M. marinum Tn-mutant 8G10 contains a Tn insertion in the promoter region of 
MMAR0978, a gene encoding an O-methyl transferase. Its homologue in M. 
tuberculosis, mmaA3 (Rv0643c), is responsible for the biosynthesis of 
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methoxymycolic acids (Yuan & Barry, 1996). Lipid analysis of this M. marinum 8G10 
mutant showed no difference in lipid profiles, whilst the analysis of the sub-classes of 
mycolates demonstrated a dramatic decrease in methoxymycolate production. This 
decrease was restored by complementing the mutant with M. marinum MMAR0978 
and M. tuberculosis mmaA3 (Rv0643c), respectively, indicating MMAR0978 has the 
same function as mmaA3 for methoxymycolic acid production. Methoxymycolates 
together with ketomycolates have been reported to be necessary for virulence in M. 
tuberculosis (Dubnau et al., 2000), although these two groups have never been studied 
separately. As a pathogenic Mycobacterium and fish pathogen, a M. marinum 
methoxymycolic acid deficient mutant will allow us to study the function of 
methoxymycolic acid in virulence. A murine bone marrow derived macrophage was 
used to see if there was any difference in intracellular survival between the wild type 
strain and the mutant and no differences were observed. However, by using the 
zebrafish infection model, the 8G10 mutant was deficient in infecting zebrafish 
embryos. This experiment is still ongoing and the mutant will be further analyse in 
adult fish for virulence and granuloma formation. 
In mycobacteria, phages have made an enormous contribution towards 
developing genetic tools for manipulation of mycobacteria (Bardarov et al., 1997; 
Jacobs et al., 1989b; van Kessel et al., 2008). Mycobacteriophage infection starts with 
its binding to a receptor on the bacterial cell surface, given that phage receptors are 
expected to be cell wall components, the study of phage-resistant mutants defective in 
phage adsorption is a promising strategy to identify phage receptors, as well as genes 
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in their biosynthetic pathways. The generalised transducing phage I3 was chosen for 
screening two M. smegmatis Tn-mutant libraries for phage resistant mutants, and 
altogether four I3-resistant mutants were identified. Compared to the wild type strain, 
phage I3-resistant mutants failed to inject DNA after pre-adsorption with I3 phage, 
suggesting that the resistance was caused be the failure of initiating infection. 
Sequencing results showed that all four mutants had Tn insertion in the same cluster 
that were involved in the biosynthesis of GPLs. Lipid analysis further confirmed the 
loss of GPLs in all four mutants. Meanwhile, by using another two 
mycobacteriophages, D29 and BxZ1, the resistance to phage I3 was specifically 
caused by the loss of GPLs, indicating GPLs may be the receptor for phage I3 
infection in M. smegmatis. GPLs can be sub-classified according to the levels of 
glycosylation. To further identify the minimal phage I3 receptor in M. smegmatis, a 
set of previously described M. smegmatis mutants that produced truncated GPL 
intermediates (Miyamoto et al., 2006), by specifically deleting three 
glycosyltransferases gtf1, gtf2, or gtf3 in M. smegmatis, were analysed. The results 
showed that the product of gtf1, a FATP core containing a single di or 
tri-O-methylated rhamnose, was sufficient for phage I3 binding and initiate the 
infection as the minimal receptor. This study demonstrated the potential use 
phage-resistance mutants for cell wall biosynthetic studies. Currently, more than 250 
mycobacteriophages have been isolated (Barksdale & Kim, 1977; Stover et al., 1991). 
Their diversity in genome sequences, morphology and host range (Pedulla et al., 2003) 
indicate different cell wall components are used as receptors. In addition, a better 
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understanding of phages receptors may also aid the further development of phage as 
diagnostic tools in clinical and genetic tools for basic research. A previously reported 
phage resistance related gene, mpr (MSMEG1236), was chosen for this study. 
Although, this gene has been reported to confer phage resistance to phage D29 and L5 
when overexpressed in M. smegmatis (Barsom & Hatfull, 1996), results indicate that 
it must be involved in cell wall composition related processes. Unfortunately, there 
were no differences in the phage resistance phenotype, as well as cell wall 
components, in both mpr knock-out mutant and the mpr overexpressed strain.  
By using Tn mutagenesis, two different strategies, colony morphology and phage 
resistance have been used to screen for cell wall deficient mutants, using both M. 
smegmatis and M. marinum (only for morphology screen). The hypothesis is that 
altered colony morphology indicates changes in cell wall components and the failure 
of phage infection is possibly related to the loss of specific cell wall components as 
receptors. Amongst the genes identified in both screens, the majority were related to 
cell wall biosynthesis or lipid metabolism, as expected. However, some of them 
appeared not to be related to the cell wall directly, which offered opportunities to 
follow up the study and understand colony morphology and cell wall biosynthesis 
from a different perspective. Therefore, these studies have demonstrated that both 
strategies showed prospects for mycobacterial cell wall biosynthesis analyses.  
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7.1 Extraction of genomic DNA - cetyltrimethyl ammonium bromide 
(CTAB)-lysozyme method 
Cells were harvested from a 10ml overnight bacterial culture by centrifugation 
and washed with a glucose Tris-EDTA (GTE) solution (25mM Tris-HCl pH 8.0, 
10mM EDTA, 50mM glucose). Cells were resuspended in 500µl GTE solution with 
10 mg/ml lysozyme and incubated at 37°C overnight. After 10% sodium dodecyl 
sulfate (100µl) and 50µl of 10mg/ml Proteinase K (Sigma, cat. P4914) were added, 
the mixture was incubated at 55°C for 20 - 40 min. 5M NaCl (200µl) and preheated 
CTAB solution (160µl) were added and the mixture incubated at 65°C for 10 min. 
Chloroform extraction was performed twice to exclude protein before DNA was 
precipitated with 560µl of isopropanol (0.7 volume of total mixture). The DNA pellet 
was washed with 70% ethanol and air-dried before dissolved in Tris buffer (10 mM 
Tris-Cl, pH 8.5) or water.  
7.2 Preparation of chemical competent E. coli cells 
A single colony of E. coli was inoculated into 2.5ml LB medium and incubated at 
37°C overnight. The overnight culture was then used to inoculate 250ml LB medium 
with 20mM MgSO4. Cells were grown to OD600 of 0.4-0.6 and then harvested by 
centrifugation at 4500g for 5 min at 4°C. Cell pellets were gently resuspended in 0.4 
volume of ice-cold TFB1 (30mM potassium acetate, 10mM CaCl2, 50mM MnCl2, 
100mM RbCl, 15% glycerol, filter-sterilised and stored at 4°C) and resuspended cells 
were incubated on ice for 5 min. Cells were harvested by centrifugation as described 
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previously and were then gently resuspended in 1/25 of the volume of ice-cold TFB2 
(10mM MOPS or PIPES, pH 6.5, 75mM CaCl2, 10mM RbCl, 15% glycerol, 
filter-sterilised and stored at 4°C). Cells were incubated on ice for 15-60 min and then 
stored as 100µl aliquots at -70°C.  
7.3 Transformation of E. coli competent cells 
E. coli competent cells were thawed on ice and then the ligation reaction (5µl) 
was added to the cells. Cells and the ligation reaction were mixed gently and then 
incubated on ice for 30 min. After heat shock at 42°C for 90 sec, the cells were placed 
on ice to cool. LB medium (1ml) was added into the tube and incubated at 37°C for 
about 45 min with shaking. The cells were then plated onto selection plates.  
7.4 Preparation of mycobacterial electrocompetent cells  
Mid-log phase mycobacterial cells were washed with 1 volume (original volume 
of culture) of the 10% glycerol (filter-sterilized, pre-cooled) twice and harvested by 
centrifugation at 4°C. Cells were resuspended in 1/10 volume of 10% glycerol and 
aliquoted (200µl) for storage at -70°C. 
7.5 Electroporation of mycobacteria 
Electrocompetent cells were thawed on ice and no more than 5μl of plasmid 
dissolved in water was added. Cells were placed into a 1mm cuvette and 
electroporated at 1800kv. TSB (1ml)  (for M. marinum, 7H9 was used) was added 
Chapter 7 General Material and Method  
 140
and cells were recovered at 37°C (for M. marinum at 30°C) for at least one generation 
time before plated on TSB (M. smegmatis) or 7H10 (M. marinum) agar with 
antibiotics.  
7.6 Radioactive labeling of lipids 
Mid-log phase mycobacterial cultures (5ml) were labeled with 50μCi of [14C] 
acetate acid (50mCi/ml, Amersham Pharmacia Biotech) and incubated for 4-6 hours. 
The [14C]-labeled cells were harvested by centrifugation and washed with PBS before 
freeze-drying. 
7.7 Lipid extraction 
[14C]-labeled polar and non-polar lipids were extracted using the methods 
described by Dobson et al (Dobson et al., 1985). The dried [14C]-labeled cells were 
mixed with 2ml of CH3OH/0.3% NaCl (100:10, v/v) and 1ml of petroleum ether (b.p. 
60-80°C) for 15 min. The mixture was centrifuged and the upper layer removed and 
stored. Petroleum ether (1ml) was added to the lower fraction and the mixture was 
mixed and centrifuged as previously described. The combined upper layers containing 
the non-polar lipids were dried and dissolved in 200µl of CHCl3/CH3OH (2:1, v/v); 
5µl was dried in a scintillation vial and then mixed with 5 ml scintillation fluid and 
radioactivity measured. The polar lipids were further extracted by adding 2.3ml of 
CHCl3/CH3OH/0.3 % NaCl (90:100:30, v/v/v) to the lower aqueous layer. The 
solution was mixed for 1 hour and centrifuged and the supernatant removed and stored. 
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The above step was repeated twice by the addition of 0.75ml of CHCl3/CH3OH/0·3 % 
NaCl (50: 100: 40, v/v/v) and mixing for 30 min. Defatted cells were kept for further 
analysis. A solution of CHCl3/0.3 % NaCl (1:1, v/v) (2.6ml) was added to the pooled 
supernatants, mixed for 5 min, centrifuged and the lower layer recovered and dried. 
The polar lipids were dissolved in 200µl of CHCl3/CH3OH (2:1, v/v); and 5µl was 
dried in a scintillation vial and then mixed with 10 ml scintillation fluid and its 
radioactivity measured.  
7.8 Thin layer chromatography (TLC) analysis for lipids 
Equivalent amounts (10,000 to 20,000 cpm) of each sample were spotted on TLC 
plates (5554 silica gel 60F524; Merck) for further 1D- or 2D-TLC analysis using 
following solution systems. [14C]-labeled lipids were revealed by overnight exposure 
to Kodak X-Omat AR film. 
Table 7.1 Developing system of 2D- TLC analysis for lipid 
System1 Direction 1 Direction 2 
A2 
Petroleum Ether (b.p. 60-80°C)/ Ethyl Acetate  
98 : 2 (v/v) 
Petroleum Ether (b.p. 60-80°C)/Acetone       
92 : 8 (v/v) 
B2 
Petroleum Ether (b.p. 60-80°C)/Acetone     
92 : 8 (v/v) 
Toluene/Acetone                
95 : 5 (v/v) 
C 
Chloroform/Methanol            
96 : 4 (v/v) 
Toluene/Acetone                
80 : 20(v/v) 
D 
Chloroform/ Methanol /Water         
100 : 14 : 0.8 (v/v/v) 
Chloroform/Acetone/ Methanol /Water       
50 : 60 : 2.5 : 3 (v/vv/v) 
E3 
Chloroform/ Methanol /Water         
60 : 30 : 6 (v/v/v) 
Chloroform/Acetic Acid/ Methanol /Water      
40 : 25 : 3 : 6 (v/vv/v) 
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1. System A, B, C and D are for non-polar lipid analysis; System D and E are for polar lipid analysis. 
2. Direction 1 of both system A and B was run for 3 times and allow plates to dry between each run. 
3. At least 1 hour drying period for direction 1 of system E. 
7.9 FAMEs and MAMEs extraction from defatted cells and whole cells 
The [14C]-labeled cells or defatted cells were subjected to alkaline hydrolysis 
using 15% aqueous tetrabutylammonium hydroxide at 100°C overnight. CH2Cl2 (4ml), 
CH3I (300μl) and water (2ml) was added to the reaction mixture followed by mixing 
for 30 min. The upper aqueous phase was discarded, and the lower organic phase was 
washed twice with water and evaporated to dryness. MAMEs were redissolved in 
diethyl-ether, and the solution was evaporated to dryness. The final residue was 
dissolved in CH2Cl2 (200μl) and 5μl of the resulting solution was used for liquid 
scintillation counting.   
7.10 TLC analysis for FAMEs and MAMEs 
The FAMEs/MAMEs mixture (10,000 cpm) was subjected to TLC (5554 silica 
gel 60F524; Merck), developed in petroleum ether (b.p. 60°C-80°C):acetone (95:5, 
v/v). [14C]-labeled FAMEs/MAMEs were revealed by overnight exposure to Kodak 
X-Omat AR film. 
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